{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 59126, "items": [{"indexed": {"date-parts": [[2018, 12, 31]], "date-time": "2018-12-31T12:42:41Z", "timestamp": 1546260161499}, "reference-count": 31, "publisher": "Elsevier BV", "issue": "12", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 12, 1]], "date-time": "2009-12-01T00:00:00Z", "timestamp": 1259625600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Waste Management"], "published-print": {"date-parts": [[2009, 12]]}, "DOI": "10.1016/j.wasman.2009.07.013", "type": "journal-article", "created": {"date-parts": [[2009, 9, 1]], "date-time": "2009-09-01T08:30:59Z", "timestamp": 1251793859000}, "page": "2983-2993", "source": "Crossref", "is-referenced-by-count": 17, "title": ["Influence of zinc chloride addition on the chemical structure of bio-oil obtained during co-pyrolysis of wood/synthetic polymer blends"], "prefix": "10.1016", "volume": "29", "author": [{"given": "Piotr", "family": "Rutkowski", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Waste Management"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0956053X09003109?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0956053X09003109?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 17]], "date-time": "2018-12-17T12:24:44Z", "timestamp": 1545049484000}, "score": 23.891918, "issued": {"date-parts": [[2009, 12]]}, "references-count": 31, "journal-issue": {"published-print": {"date-parts": [[2009, 12]]}, "issue": "12"}, "alternative-id": ["S0956053X09003109"], "URL": "http://dx.doi.org/10.1016/j.wasman.2009.07.013", "ISSN": ["0956-053X"], "issn-type": [{"value": "0956-053X", "type": "print"}], "subject": ["Waste Management and Disposal"]}, {"indexed": {"date-parts": [[2018, 6, 8]], "date-time": "2018-06-08T04:39:08Z", "timestamp": 1528432748416}, "reference-count": 16, "publisher": "Future Medicine Ltd", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Melanoma Management"], "published-print": {"date-parts": [[2017, 5]]}, "DOI": "10.2217/mmt-2017-0004", "type": "journal-article", "created": {"date-parts": [[2017, 5, 15]], "date-time": "2017-05-15T14:38:03Z", "timestamp": 1494859083000}, "page": "83-87", "source": "Crossref", "is-referenced-by-count": 0, "title": ["What is new in melanoma after European Cancer Congress 2017?"], "prefix": "10.2217", "volume": "4", "author": [{"given": "Piotr", "family": "Rutkowski", "sequence": "first", "affiliation": [{"name": "Department of Soft Tissue/Bone Sarcoma &amp; Melanoma, Maria Sklodowska-Curie Institute \u2013 Oncology Center, Roentgena 5, 02\u2013781 Warsaw, Poland"}]}], "member": "1057", "reference": [{"key": "B1", "DOI": "10.1016/S0959-8049(17)30484-7", "doi-asserted-by": "publisher"}, {"key": "B2", "DOI": "10.1016/j.ejso.2016.12.001", "doi-asserted-by": "publisher"}, {"key": "B3", "DOI": "10.1016/j.ejca.2016.05.005", "doi-asserted-by": "publisher"}, {"key": "B5", "DOI": "10.1016/j.ejca.2015.09.013", "doi-asserted-by": "publisher"}, {"key": "B6", "DOI": "10.1016/S0959-8049(17)30485-9", "doi-asserted-by": "publisher"}, {"key": "B7", "author": "Long G", "first-page": "27", "year": "2017", "volume-title": "2017 European Cancer Conference."}, {"key": "B8", "author": "Amaria R", "first-page": "27", "year": "2017", "volume-title": "2017 European Cancer Conference."}, {"issue": "6", "key": "B9", "first-page": "1", "volume": "27", "author": "Blank CU", "year": "2016", "journal-title": "Ann. Oncol."}, {"key": "B10", "DOI": "10.1056/NEJMoa1611299", "doi-asserted-by": "publisher"}, {"key": "B11", "DOI": "10.1016/S1470-2045(17)30015-3", "doi-asserted-by": "publisher"}, {"key": "B12", "DOI": "10.1016/S0959-8049(17)30097-7", "doi-asserted-by": "publisher"}, {"key": "B13", "DOI": "10.1016/S0959-8049(17)30499-9", "doi-asserted-by": "publisher"}, {"key": "B14", "DOI": "10.1016/S0959-8049(17)30482-3", "doi-asserted-by": "publisher"}, {"key": "B15", "DOI": "10.1016/S0959-8049(17)30483-5", "doi-asserted-by": "publisher"}, {"key": "B16", "DOI": "10.1200/JCO.2016.67.9258", "doi-asserted-by": "publisher"}, {"key": "B17", "DOI": "10.1016/S0959-8049(17)30500-2", "doi-asserted-by": "publisher"}], "container-title": ["Melanoma Management"], "language": "en", "link": [{"URL": "http://www.futuremedicine.com/doi/pdf/10.2217/mmt-2017-0004", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 6, 7]], "date-time": "2018-06-07T20:09:53Z", "timestamp": 1528402193000}, "score": 23.891918, "issued": {"date-parts": [[2017, 5]]}, "references-count": 16, "journal-issue": {"published-print": {"date-parts": [[2017, 5]]}, "issue": "2"}, "alternative-id": ["10.2217/mmt-2017-0004"], "URL": "http://dx.doi.org/10.2217/mmt-2017-0004", "relation": {"cites": []}, "ISSN": ["2045-0885", "2045-0893"], "issn-type": [{"value": "2045-0885", "type": "print"}, {"value": "2045-0893", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T16:47:17Z", "timestamp": 1525798037871}, "reference-count": 0, "publisher": "VM Media SP. zo.o VM Group SK", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.5603/njo.2016.0009", "type": "journal-article", "created": {"date-parts": [[2016, 7, 5]], "date-time": "2016-07-05T09:40:35Z", "timestamp": 1467711635000}, "page": "68-69", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Czas prze\u017cycia wolnego od progresji choroby nie jest wiarygodnym kryterium oceny warto\u015bci przeciwnowotworowego leczenia systemowego"], "prefix": "10.5603", "volume": "66", "author": [{"given": "Piotr", "family": "Rutkowski", "sequence": "first", "affiliation": []}], "member": "3595", "published-online": {"date-parts": [[2016, 4, 7]]}, "container-title": ["Nowotwory. Journal of Oncology"], "link": [{"URL": "https://journals.viamedica.pl/nowotwory_journal_of_oncology/article/viewFile/45379/31316", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 12, 28]], "date-time": "2017-12-28T11:55:37Z", "timestamp": 1514462137000}, "score": 23.891918, "issued": {"date-parts": [[2016, 4, 7]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016, 4, 7]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.5603/njo.2016.0009", "ISSN": ["2300-2115", "0029-540X"], "issn-type": [{"value": "0029-540X", "type": "print"}, {"value": "2300-2115", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 10, 15]], "date-time": "2018-10-15T23:40:16Z", "timestamp": 1539646816827}, "reference-count": 40, "publisher": "Elsevier BV", "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Journal of Analytical and Applied Pyrolysis"], "published-print": {"date-parts": [[2013, 11]]}, "DOI": "10.1016/j.jaap.2013.05.006", "type": "journal-article", "created": {"date-parts": [[2013, 5, 18]], "date-time": "2013-05-18T22:42:59Z", "timestamp": 1368916979000}, "page": "609-617", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Characteristics of bio-oil obtained by catalytic pyrolysis of beverage carton packaging waste"], "prefix": "10.1016", "volume": "104", "author": [{"given": "Piotr", "family": "Rutkowski", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Journal of Analytical and Applied Pyrolysis"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0165237013000971?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0165237013000971?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 15]], "date-time": "2018-10-15T23:23:03Z", "timestamp": 1539645783000}, "score": 23.891918, "issued": {"date-parts": [[2013, 11]]}, "references-count": 40, "alternative-id": ["S0165237013000971"], "URL": "http://dx.doi.org/10.1016/j.jaap.2013.05.006", "ISSN": ["0165-2370"], "issn-type": [{"value": "0165-2370", "type": "print"}], "subject": ["General Chemistry", "General Chemical Engineering"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Characteristics of bio-oil obtained by catalytic pyrolysis of beverage carton packaging waste", "name": "articletitle", "label": "Article Title"}, {"value": "Journal of Analytical and Applied Pyrolysis", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.jaap.2013.05.006", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2013 Elsevier B.V. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2018, 11, 27]], "date-time": "2018-11-27T02:10:13Z", "timestamp": 1543284613859}, "reference-count": 49, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 5, 1]], "date-time": "2012-05-01T00:00:00Z", "timestamp": 1335830400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Analytical and Applied Pyrolysis"], "published-print": {"date-parts": [[2012, 5]]}, "DOI": "10.1016/j.jaap.2012.01.003", "type": "journal-article", "created": {"date-parts": [[2012, 1, 17]], "date-time": "2012-01-17T12:59:56Z", "timestamp": 1326805196000}, "page": "38-47", "source": "Crossref", "is-referenced-by-count": 15, "title": ["Chemical composition of bio-oil produced by co-pyrolysis of biopolymer/polypropylene mixtures with K2CO3 and ZnCl2 addition"], "prefix": "10.1016", "volume": "95", "author": [{"given": "Piotr", "family": "Rutkowski", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Journal of Analytical and Applied Pyrolysis"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0165237012000058?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0165237012000058?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 27]], "date-time": "2018-11-27T01:58:05Z", "timestamp": 1543283885000}, "score": 23.891918, "issued": {"date-parts": [[2012, 5]]}, "references-count": 49, "alternative-id": ["S0165237012000058"], "URL": "http://dx.doi.org/10.1016/j.jaap.2012.01.003", "ISSN": ["0165-2370"], "issn-type": [{"value": "0165-2370", "type": "print"}], "subject": ["General Chemistry", "General Chemical Engineering"]}, {"indexed": {"date-parts": [[2018, 12, 28]], "date-time": "2018-12-28T18:22:38Z", "timestamp": 1546021358967}, "reference-count": 35, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 11, 1]], "date-time": "2012-11-01T00:00:00Z", "timestamp": 1351728000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Analytical and Applied Pyrolysis"], "published-print": {"date-parts": [[2012, 11]]}, "DOI": "10.1016/j.jaap.2012.07.012", "type": "journal-article", "created": {"date-parts": [[2012, 8, 19]], "date-time": "2012-08-19T17:18:02Z", "timestamp": 1345396682000}, "page": "115-122", "source": "Crossref", "is-referenced-by-count": 17, "title": ["Pyrolytic behavior of cellulose in presence of montmorillonite K10 as catalyst"], "prefix": "10.1016", "volume": "98", "author": [{"given": "Piotr", "family": "Rutkowski", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Journal of Analytical and Applied Pyrolysis"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0165237012001465?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0165237012001465?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 21]], "date-time": "2018-11-21T10:55:43Z", "timestamp": 1542797743000}, "score": 23.891918, "issued": {"date-parts": [[2012, 11]]}, "references-count": 35, "alternative-id": ["S0165237012001465"], "URL": "http://dx.doi.org/10.1016/j.jaap.2012.07.012", "ISSN": ["0165-2370"], "issn-type": [{"value": "0165-2370", "type": "print"}], "subject": ["General Chemistry", "General Chemical Engineering"]}, {"indexed": {"date-parts": [[2018, 12, 28]], "date-time": "2018-12-28T18:22:38Z", "timestamp": 1546021358968}, "reference-count": 39, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 11, 1]], "date-time": "2012-11-01T00:00:00Z", "timestamp": 1351728000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Analytical and Applied Pyrolysis"], "published-print": {"date-parts": [[2012, 11]]}, "DOI": "10.1016/j.jaap.2012.07.010", "type": "journal-article", "created": {"date-parts": [[2012, 7, 28]], "date-time": "2012-07-28T16:48:13Z", "timestamp": 1343494093000}, "page": "86-97", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Catalytic effects of copper(II) chloride and aluminum chloride on the pyrolytic behavior of cellulose"], "prefix": "10.1016", "volume": "98", "author": [{"given": "Piotr", "family": "Rutkowski", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Journal of Analytical and Applied Pyrolysis"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0165237012001350?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0165237012001350?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 21]], "date-time": "2018-11-21T20:30:27Z", "timestamp": 1542832227000}, "score": 23.891918, "issued": {"date-parts": [[2012, 11]]}, "references-count": 39, "alternative-id": ["S0165237012001350"], "URL": "http://dx.doi.org/10.1016/j.jaap.2012.07.010", "ISSN": ["0165-2370"], "issn-type": [{"value": "0165-2370", "type": "print"}], "subject": ["General Chemistry", "General Chemical Engineering"]}, {"indexed": {"date-parts": [[2018, 6, 1]], "date-time": "2018-06-01T02:42:30Z", "timestamp": 1527820950204}, "reference-count": 37, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 4, 1]], "date-time": "2006-04-01T00:00:00Z", "timestamp": 1143849600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Energy Conversion and Management"], "published-print": {"date-parts": [[2006, 4]]}, "DOI": "10.1016/j.enconman.2005.05.017", "type": "journal-article", "created": {"date-parts": [[2005, 7, 15]], "date-time": "2005-07-15T13:34:03Z", "timestamp": 1121434443000}, "page": "716-731", "source": "Crossref", "is-referenced-by-count": 58, "title": ["Influence of polystyrene addition to cellulose on chemical structure and properties of bio-oil obtained during pyrolysis"], "prefix": "10.1016", "volume": "47", "author": [{"given": "Piotr", "family": "Rutkowski", "sequence": "first", "affiliation": []}, {"given": "Andrzej", "family": "Kubacki", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Energy Conversion and Management"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S019689040500138X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S019689040500138X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 16]], "date-time": "2017-06-16T21:15:33Z", "timestamp": 1497647733000}, "score": 21.802963, "issued": {"date-parts": [[2006, 4]]}, "references-count": 37, "journal-issue": {"published-print": {"date-parts": [[2006, 4]]}, "issue": "6"}, "alternative-id": ["S019689040500138X"], "URL": "http://dx.doi.org/10.1016/j.enconman.2005.05.017", "ISSN": ["0196-8904"], "issn-type": [{"value": "0196-8904", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 6, 7]], "date-time": "2018-06-07T13:02:26Z", "timestamp": 1528376546589}, "reference-count": 30, "publisher": "Informa Healthcare", "issue": "1", "content-domain": {"domain": ["www.tandfonline.com"], "crossmark-restriction": true}, "short-container-title": ["Expert Opinion on Drug Safety"], "published-print": {"date-parts": [[2016, 1, 2]]}, "DOI": "10.1517/14740338.2016.1122754", "type": "journal-article", "created": {"date-parts": [[2015, 11, 19]], "date-time": "2015-11-19T12:03:07Z", "timestamp": 1447934587000}, "page": "105-116", "update-policy": "http://dx.doi.org/10.1080/tandf_crossmark_01", "source": "Crossref", "is-referenced-by-count": 6, "title": ["The safety of regorafenib for the treatment of gastrointestinal stromal tumors"], "prefix": "10.1517", "volume": "15", "author": [{"given": "Piotr", "family": "Rutkowski", "sequence": "first", "affiliation": []}, {"given": "Joanna", "family": "St\u0119pniak", "sequence": "additional", "affiliation": []}], "member": "3197", "published-online": {"date-parts": [[2015, 12, 11]]}, "reference": [{"key": "CIT0002", "DOI": "10.1007/BF03256278", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "DOI": "10.1093/annonc/mdu255", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "DOI": "10.1200/JCO.2008.17.4284", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "DOI": "10.1586/era.09.171", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "DOI": "10.1056/NEJMoa020461", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "DOI": "10.1007/s12032-013-0765-7", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "DOI": "10.1158/1078-0432.CCR-04-2245", "doi-asserted-by": "publisher"}, {"key": "CIT0009", "DOI": "10.1016/S0140-6736(06)69446-4", "doi-asserted-by": "publisher"}, {"key": "CIT0010", "DOI": "10.1177/1758834014544892", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.1002/ijc.25864", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "DOI": "10.1007/s11523-014-0333-x", "doi-asserted-by": "publisher"}, {"key": "CIT0014", "DOI": "10.1517/14656566.2014.877888", "doi-asserted-by": "publisher"}, {"key": "CIT0015", "DOI": "10.1158/0008-5472.CAN-04-1443", "doi-asserted-by": "publisher"}, {"key": "CIT0017", "DOI": "10.1158/1078-0432.CCR-11-1900", "doi-asserted-by": "publisher"}, {"key": "CIT0018", "DOI": "10.1038/bjc.2012.153", "doi-asserted-by": "publisher"}, {"key": "CIT0019", "DOI": "10.1200/JCO.2011.39.9394", "doi-asserted-by": "publisher"}, {"key": "CIT0020", "author": "Van den Abbeele AD", "volume": "29", "first-page": "10050", "year": "2011", "journal-title": "J Clin Oncol", "DOI": "10.1200/jco.2011.29.15_suppl.10050", "doi-asserted-by": "crossref"}, {"key": "CIT0021", "author": "George S", "volume": "31", "first-page": "1051", "year": "2013", "journal-title": "ASCO Meet Abstr"}, {"key": "CIT0022", "DOI": "10.1016/S0140-6736(12)61857-1", "doi-asserted-by": "publisher"}, {"key": "CIT0023", "DOI": "10.1016/j.ejca.2013.11.037", "doi-asserted-by": "publisher"}, {"key": "CIT0024", "DOI": "10.1200/JCO.2012.45.5766", "doi-asserted-by": "publisher"}, {"key": "CIT0025", "DOI": "10.1634/theoncologist.2013-0059", "doi-asserted-by": "publisher"}, {"key": "CIT0026", "DOI": "10.1007/s00520-013-2085-z", "doi-asserted-by": "publisher"}, {"key": "CIT0027", "DOI": "10.1007/s10120-014-0391-x", "doi-asserted-by": "publisher"}, {"key": "CIT0028", "DOI": "10.1177/1758834014522491", "doi-asserted-by": "publisher"}, {"issue": "8", "key": "CIT0029", "first-page": "2061", "volume": "30", "author": "Wu L", "year": "2014", "journal-title": "Drug Des Devel Ther"}, {"key": "CIT0030", "author": "Jones RL", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "CIT0031", "DOI": "10.1007/s40265-015-0406-x", "doi-asserted-by": "publisher"}, {"key": "CIT0032", "DOI": "10.1016/S1470-2045(09)70017-8", "doi-asserted-by": "publisher"}, {"key": "CIT0033", "author": "Heinrich MC", "volume": "31", "year": "2013", "journal-title": "J Clin Oncol"}], "container-title": ["Expert Opinion on Drug Safety"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1517/14740338.2016.1122754", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 23]], "date-time": "2017-06-23T23:59:26Z", "timestamp": 1498262366000}, "score": 21.802963, "issued": {"date-parts": [[2015, 12, 11]]}, "references-count": 30, "journal-issue": {"published-online": {"date-parts": [[2015, 12, 9]]}, "published-print": {"date-parts": [[2016, 1, 2]]}, "issue": "1"}, "alternative-id": ["10.1517/14740338.2016.1122754"], "URL": "http://dx.doi.org/10.1517/14740338.2016.1122754", "relation": {"cites": []}, "ISSN": ["1474-0338", "1744-764X"], "issn-type": [{"value": "1474-0338", "type": "print"}, {"value": "1744-764X", "type": "electronic"}], "assertion": [{"value": "The publishing and review policy for this title is described in its Aims & Scope.", "order": 1, "name": "peerreview_statement", "label": "Peer Review Statement"}, {"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ieds20", "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ieds20", "order": 2, "name": "aims_and_scope_url", "label": "Aim & Scope"}]}, {"indexed": {"date-parts": [[2018, 5, 7]], "date-time": "2018-05-07T18:31:02Z", "timestamp": 1525717862260}, "publisher-location": "Boston, MA", "reference-count": 0, "publisher": "Springer US", "isbn-type": [{"value": "9781475710205", "type": "print"}, {"value": "9780387355269", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2000]]}, "DOI": "10.1007/978-0-387-35526-9_8", "type": "book-chapter", "created": {"date-parts": [[2013, 6, 4]], "date-time": "2013-06-04T20:55:15Z", "timestamp": 1370379315000}, "page": "89-99", "source": "Crossref", "is-referenced-by-count": 0, "title": ["A Picocellular CDMA/TDD Overlay on GSM"], "prefix": "10.1007", "author": [{"given": "Piotr", "family": "Kaczorek", "sequence": "first", "affiliation": []}, {"given": "Dominik", "family": "Rutkowski", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Personal Wireless Communications"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-0-387-35526-9_8", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2013, 6, 4]], "date-time": "2013-06-04T20:55:54Z", "timestamp": 1370379354000}, "score": 21.802963, "issued": {"date-parts": [[2000]]}, "ISBN": ["9781475710205", "9780387355269"], "references-count": 0, "URL": "http://dx.doi.org/10.1007/978-0-387-35526-9_8"}, {"indexed": {"date-parts": [[2018, 5, 7]], "date-time": "2018-05-07T12:15:37Z", "timestamp": 1525695337530}, "reference-count": 0, "publisher": "VM Media SP. zo.o VM Group SK", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.5603/njo.2015.0019", "type": "journal-article", "created": {"date-parts": [[2015, 5, 22]], "date-time": "2015-05-22T06:20:07Z", "timestamp": 1432275607000}, "page": "93-95", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Badania kliniczne w obliczu nowych przepis\u00f3w Unii Europejskiej, nowe mo\u017cliwo\u015bci realizacji niekomercyjnych bada\u0144 klinicznych w Polsce"], "prefix": "10.5603", "volume": "65", "author": [{"given": "Agnieszka", "family": "Byszek", "sequence": "first", "affiliation": []}, {"given": "Piotr", "family": "Rutkowski", "sequence": "additional", "affiliation": []}], "member": "3595", "published-online": {"date-parts": [[2015, 5, 6]]}, "container-title": ["Nowotwory. Journal of Oncology"], "link": [{"URL": "https://journals.viamedica.pl/nowotwory_journal_of_oncology/article/viewFile/41950/28590", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 12, 28]], "date-time": "2017-12-28T11:58:09Z", "timestamp": 1514462289000}, "score": 21.802963, "issued": {"date-parts": [[2015, 5, 6]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2015, 5, 6]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.5603/njo.2015.0019", "ISSN": ["2300-2115", "0029-540X"], "issn-type": [{"value": "0029-540X", "type": "print"}, {"value": "2300-2115", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 4, 17]], "date-time": "2018-04-17T08:45:34Z", "timestamp": 1523954734241}, "reference-count": 0, "publisher": "VM Media SP. zo.o VM Group SK", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.5603/njo.2016.0039", "type": "journal-article", "created": {"date-parts": [[2016, 8, 18]], "date-time": "2016-08-18T07:41:50Z", "timestamp": 1471506110000}, "page": "234-237", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Talimogen laherparepwek (T-VEC) \u2014 nowa terapia czerniak\u00f3w sk\u00f3ry zmodyfikowanym genetycznie wirusem onkolitycznym"], "prefix": "10.5603", "volume": "66", "author": [{"given": "Piotr", "family": "Rutkowski", "sequence": "first", "affiliation": []}, {"given": "Marcin", "family": "Zdzienicki", "sequence": "additional", "affiliation": []}], "member": "3595", "published-online": {"date-parts": [[2016, 7, 13]]}, "container-title": ["Nowotwory. Journal of Oncology"], "link": [{"URL": "https://journals.viamedica.pl/nowotwory_journal_of_oncology/article/viewFile/48075/35363", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 12, 28]], "date-time": "2017-12-28T11:54:55Z", "timestamp": 1514462095000}, "score": 21.802963, "issued": {"date-parts": [[2016, 7, 13]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016, 7, 13]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.5603/njo.2016.0039", "ISSN": ["2300-2115", "0029-540X"], "issn-type": [{"value": "0029-540X", "type": "print"}, {"value": "2300-2115", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T16:28:03Z", "timestamp": 1525796883593}, "reference-count": 32, "publisher": "Springer Nature", "issue": "2", "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["memo"], "published-print": {"date-parts": [[2014, 5]]}, "DOI": "10.1007/s12254-014-0151-y", "type": "journal-article", "created": {"date-parts": [[2014, 6, 23]], "date-time": "2014-06-23T08:25:40Z", "timestamp": 1403511940000}, "page": "83-86", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Follow-up in melanoma patients"], "prefix": "10.1007", "volume": "7", "author": [{"given": "Piotr", "family": "Rutkowski", "sequence": "first", "affiliation": []}, {"given": "Iwona", "family": "\u0141ugowska", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2014, 6, 24]]}, "reference": [{"key": "151_CR1", "doi-asserted-by": "crossref", "first-page": "804", "DOI": "10.1245/s10434-009-0318-7", "volume": "16", "author": "AB Francken", "year": "2009", "unstructured": "Francken AB, Hoekstra HJ. Follow-up of melanoma patients: the need for evidence-based protocols. Ann Surg Oncol. 2009;16:804\u20135.", "journal-title": "Ann Surg Oncol"}, {"key": "151_CR2", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1016/j.soc.2010.09.009", "volume": "20", "author": "RC Fields", "year": "2011", "unstructured": "Fields RC, Coit DG. Evidence-based follow-up for the patient with melanoma. Surg Oncol Clin N Am. 2011;20:181\u2013200.", "journal-title": "Surg Oncol Clin N Am"}, {"key": "151_CR3", "doi-asserted-by": "crossref", "first-page": "752", "DOI": "10.1245/s10434-013-3295-9", "volume": "21", "author": "CP Scally", "year": "2014", "unstructured": "Scally CP, Wong SL. Intensity of follow-up after melanoma surgery. Ann Surg Oncol. 2014;21:752\u20137.", "journal-title": "Ann Surg Oncol"}, {"key": "151_CR4", "doi-asserted-by": "crossref", "first-page": "1703", "DOI": "10.1001/jama.1995.03530210057031", "volume": "274", "author": "M Weiss", "year": "1995", "unstructured": "Weiss M, Loprinzi CL, Creagan ET, Dalton RJ, Novotny P, O\u2019Fallon JR. Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas. JAMA. 1995;274:1703\u20135.", "journal-title": "JAMA"}, {"key": "151_CR5", "doi-asserted-by": "crossref", "first-page": "vii86", "DOI": "10.1093/annonc/mds229", "volume": "23", "author": "R Dummer", "year": "2012", "unstructured": "Dummer R, Hauschild A, Guggenheim M, Keilholz U, Pentheroudakis G. Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23:vii86\u201391.", "journal-title": "Ann Oncol"}, {"key": "151_CR6", "unstructured": "NCCN Clinical Practice Guidelines in Oncology. Melanoma v.2. 2014."}, {"key": "151_CR7", "first-page": "393e9", "volume": "17", "author": "C Garbe", "year": "2007", "unstructured": "Garbe C, Hauschild A, Volkenandt M, et al. Evidence and interdisciplinary consensus-based German guidelines: diagnosis and surveillance of melanoma. Melanoma Res. 2007;17:393e9.", "journal-title": "Melanoma Res"}, {"key": "151_CR8", "first-page": "107", "volume": "140", "author": "TM Johnson", "year": "2004", "unstructured": "Johnson TM, Bradford CR, Gruber SB, Sondak VK, Schwartz JL. Staging workup, sentinel node biopsy, and follow-up tests for melanoma: update of current concepts. Arch Dermatol. 2004;140:107\u201313.", "journal-title": "Arch Dermatol"}, {"key": "151_CR9", "first-page": "178", "volume": "8", "author": "P Rutkowski", "year": "2012", "unstructured": "Rutkowski P, Wysocki PJ, Nowecki ZI, i wsp. Cutaneous melanoma\u2014diagnostic and therapeutic guidelines in 2013. Onkologia w Praktyce Klinicznej. 2012;8:178\u201392.", "journal-title": "Onkologia w Praktyce Klinicznej."}, {"key": "151_CR10", "doi-asserted-by": "crossref", "first-page": "369", "DOI": "10.1016/S0093-7754(03)00097-6", "volume": "30", "author": "DF Christianson", "year": "2003", "unstructured": "Christianson DF, Anderson CM. Close monitoring and lifetime follow-up is optimal for patients with a history of melanoma. Semin Oncol. 2003;30:369\u201374.", "journal-title": "Semin Oncol"}, {"key": "151_CR11", "doi-asserted-by": "crossref", "first-page": "608", "DOI": "10.1016/S1470-2045(05)70283-7", "volume": "6", "author": "AB Francken", "year": "2005", "unstructured": "Francken AB, Bastiaannet E, Hoekstra HJ. Follow-up in patients with localized primary cutaneous melanoma. Lancet Oncol. 2005;6:608\u201321.", "journal-title": "Lancet Oncol"}, {"key": "151_CR12", "doi-asserted-by": "crossref", "first-page": "1924", "DOI": "10.1245/s10434-007-9347-2", "volume": "14", "author": "AB Francken", "year": "2007", "unstructured": "Francken AB, Shaw HM, Accortt NA, Soong SJ, Hoekstra HJ, Thompson JF. Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines. Ann Surg Oncol. 2007;14:1924\u201333.", "journal-title": "Ann Surg Oncol"}, {"key": "151_CR13", "doi-asserted-by": "crossref", "first-page": "1401", "DOI": "10.1002/bjs.6347", "volume": "95", "author": "AB Francken", "year": "2008", "unstructured": "Francken AB, Accortt NA, Shaw HM, et al. Follow-up schedules after treatment for malignant melanoma. Br J Surg. 2008;95:1401\u20137.", "journal-title": "Br J Surg"}, {"key": "151_CR14", "doi-asserted-by": "crossref", "first-page": "520", "DOI": "10.1200/JCO.2003.01.091", "volume": "21", "author": "C Garbe", "year": "2003", "unstructured": "Garbe C, Paul A, Kohler-Spath H, et al. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy. J Clin Oncol. 2003;21:520\u20139.", "journal-title": "J Clin Oncol"}, {"key": "151_CR15", "doi-asserted-by": "crossref", "first-page": "941", "DOI": "10.1245/s10434-008-0238-y", "volume": "16", "author": "MO Meyers", "year": "2009", "unstructured": "Meyers MO, Yeh JJ, Frank J, et al. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of utility of follow-up staging. Ann Surg Oncol. 2009;16:941\u20137.", "journal-title": "Ann Surg Oncol"}, {"key": "151_CR16", "doi-asserted-by": "crossref", "first-page": "3042", "DOI": "10.1200/JCO.2009.26.2063", "volume": "28", "author": "E Romano", "year": "2010", "unstructured": "Romano E, Scordo M, Dusza SW, Coit DG, Chapman PB. Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines. J Clin Oncol. 2010;28:3042\u20137.", "journal-title": "J Clin Oncol"}, {"key": "151_CR17", "first-page": "1", "volume": "Suppl 6", "author": "A Pflugfelder", "year": "2013", "unstructured": "Pflugfelder A, Kochs C, Blum A, et al. Malignant melanoma S3-guidline \u201cDiagnosis, therapy and follow-up of melanoma\u201d. J Dtsch Dermatol Ges. 2013;Suppl 6:1\u2013126.", "journal-title": "J Dtsch Dermatol Ges"}, {"key": "151_CR18", "doi-asserted-by": "crossref", "first-page": "602", "DOI": "10.1016/j.ejca.2013.10.019", "volume": "50", "author": "RJ Leest van der", "year": "2014", "unstructured": "van der Leest RJ, van Steenbergen LN, Hollestein LM, de Vries E, Nijsten T, van Akkooi AC, Janssen-Heijnen ML, Coebergh JW. Conditional survival of malignant melanoma in The Netherlands: 1994\u20132008. Eur J Cancer. 2014;50:602\u201310.", "journal-title": "Eur J Cancer."}, {"key": "151_CR19", "doi-asserted-by": "crossref", "first-page": "1215", "DOI": "10.1097/SLA.0000000000000233", "volume": "259", "author": "NM Rueth", "year": "2014", "unstructured": "Rueth NM, Xing Y, Chiang YJ, Cromwell KD, Ross MI, Lee JE, Gershenwald JE, Royal RE, Cormier JN. Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies. Ann Surg. 2014;259:1215\u201322.", "journal-title": "Ann Surg"}, {"issue": "35", "key": "151_CR20", "doi-asserted-by": "crossref", "first-page": "4641", "DOI": "10.1200/JCO.2010.34.2956", "volume": "29", "author": "RM Turner", "year": "2011", "unstructured": "Turner RM, Bell KJ, Morton RL, et al. Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma. J Clin Oncol. 2011;29(35):4641\u20136.", "journal-title": "J Clin Oncol"}, {"key": "151_CR21", "doi-asserted-by": "crossref", "first-page": "3707", "DOI": "10.1200/JCO.2003.99.112", "volume": "21", "author": "P Autier", "year": "2003", "unstructured": "Autier P, Coebergh JW, Boniol M, Dore JF, de Vries E, Eggermont AM. Management of melanoma patients: benefit of intense follow-up schedule is not demonstrated. J Clin Oncol. 2003;21:3707.", "journal-title": "J Clin Oncol"}, {"issue": "5", "key": "151_CR22", "doi-asserted-by": "crossref", "first-page": "463", "DOI": "10.1002/jso.23278", "volume": "107", "author": "L Rychetnik", "year": "2013", "unstructured": "Rychetnik L, McCaffery K, Morton RL, Thompson JF, Menzies SW, Irwig L. Follow-up of early stage melanoma: specialist clinician perspectives on the functions of follow-up and implications for extending follow-up intervals. J Surg Oncol. 2013;107(5):463\u20138.", "journal-title": "J Surg Oncol"}, {"key": "151_CR23", "doi-asserted-by": "crossref", "first-page": "337e41", "DOI": "10.1111/j.1365-2133.2008.08641.x", "volume": "159", "author": "J Einwachter-Thompson", "year": "2008", "unstructured": "Einwachter-Thompson J, MacKie RM. An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5\u00a0mm thick at diagnosis. Br J Dermatol. 2008;159:337e41.", "journal-title": "Br J Dermatol"}, {"key": "151_CR24", "first-page": "673e80", "volume": "5", "author": "ML Balfounta", "year": "2004", "unstructured": "Balfounta ML, Beauchet A, Chagnon S, et al. Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis. Lancet Oncol. 2004;5:673e80.", "journal-title": "Lancet Oncol"}, {"key": "151_CR25", "doi-asserted-by": "crossref", "first-page": "2409", "DOI": "10.1002/1097-0142(20010615)91:12<2409::AID-CNCR1275>3.0.CO;2-S", "volume": "91", "author": "C Voit", "year": "2001", "unstructured": "Voit C, Mayer T, Kron M, et al. Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients. Cancer. 2001;91:2409\u201316.", "journal-title": "Cancer"}, {"key": "151_CR26", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1097/CMR.0b013e328348dad3", "volume": "21", "author": "U Kruger", "year": "2011", "unstructured": "Kruger U, Kretschmer L, Thoms KM, Padeken M, Peter Bertsch H, Schon MP, Zutt M. Lymph node ultrasound during melanoma follow-up significantly improves metastasis detection compared to clinical examination alone: a study on 433 patients. Melanoma Res. 2011;21:457\u201363.", "journal-title": "Melanoma Res."}, {"key": "151_CR27", "doi-asserted-by": "crossref", "first-page": "1307", "DOI": "10.1056/NEJMoa060992", "volume": "355", "author": "DL Morton", "year": "2006", "unstructured": "Morton DL, Thompson JF, Ochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. NEJM. 2006;355:1307\u201317.", "journal-title": "NEJM"}, {"key": "151_CR28", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.1245/s10434-009-0780-2", "volume": "17", "author": "U Leiter", "year": "2010", "unstructured": "Leiter U, Buettner PG, Bohnenberger K, Eigentler T, Meier F, Moehrle M, Breuninger H, Garbe C. Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement. Ann Surg Oncol. 2010;17:129\u201337.", "journal-title": "Ann Surg Oncol."}, {"key": "151_CR29", "unstructured": "Bamboat ZM, Konstantinidis IT, Kuk D, Ariyan CE, Brady MS, Coit DG. Observation after a positive sentinel lymph node biopsy in patients with melanoma. Ann Surg Oncol. 2014; May 16 [Epub ahead of print].", "DOI": "10.1245/s10434-014-3758-7", "doi-asserted-by": "crossref"}, {"key": "151_CR30", "doi-asserted-by": "crossref", "first-page": "571", "DOI": "10.1245/s10434-008-0207-5", "volume": "16", "author": "RL Morton", "year": "2009", "unstructured": "Morton RL, Craig JC, Thompson JF. The role of surveillance chest x-rays in the follow-up of high-risk melanoma patients. Ann Surg Oncol. 2009;16:571\u20137.", "journal-title": "Ann Surg Oncol"}, {"key": "151_CR31", "first-page": "67", "volume": "140", "author": "H Tsao", "year": "2004", "unstructured": "Tsao H, Feldman M, Fullerton JE, Sober AJ, Rosenthal D, Goggins W. Early detection of asymptomatic pulmonary melanoma metastases by routine chest radiographs is not associated with improved survival. Arch Dermatol. 2004;140:67\u201370.", "journal-title": "Arch Dermatol"}, {"key": "151_CR32", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1016/j.clindermatol.2009.06.012", "volume": "28", "author": "A Forschner", "year": "2010", "unstructured": "Forschner A, Eigentler TK, Pflugfelder A, Leiter U, Weide B, Held L, Meier F, Garbe C. Melanoma staging: facts and controversies. Clin Dermatol. 2010;28:275\u201380.", "journal-title": "Clin Dermatol"}], "container-title": ["memo - Magazine of European Medical Oncology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s12254-014-0151-y", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 22]], "date-time": "2017-06-22T15:22:53Z", "timestamp": 1498144973000}, "score": 21.802963, "issued": {"date-parts": [[2014, 5]]}, "references-count": 32, "journal-issue": {"published-print": {"date-parts": [[2014, 5]]}, "issue": "2"}, "alternative-id": ["151"], "URL": "http://dx.doi.org/10.1007/s12254-014-0151-y", "relation": {"cites": []}, "ISSN": ["1865-5041", "1865-5076"], "issn-type": [{"value": "1865-5041", "type": "print"}, {"value": "1865-5076", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T02:07:56Z", "timestamp": 1525313276412}, "reference-count": 24, "publisher": "American Chemical Society (ACS)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Energy Fuels"], "published-print": {"date-parts": [[2001, 1]]}, "DOI": "10.1021/ef000085p", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T04:52:22Z", "timestamp": 1027659142000}, "page": "8-13", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Identification of Organic Sulfur Compounds in Supercritical Extracts from Polish Lignite"], "prefix": "10.1021", "volume": "15", "author": [{"given": "Gra\u017cyna", "family": "Gryglewicz", "sequence": "first", "affiliation": []}, {"given": "Piotr", "family": "Rutkowski", "sequence": "additional", "affiliation": []}], "member": "316", "container-title": ["Energy & Fuels"], "language": "en", "link": [{"URL": "http://pubs.acs.org/doi/pdf/10.1021/ef000085p", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 15]], "date-time": "2017-06-15T04:32:21Z", "timestamp": 1497501141000}, "score": 21.802963, "issued": {"date-parts": [[2001, 1]]}, "references-count": 24, "journal-issue": {"published-print": {"date-parts": [[2001, 1]]}, "issue": "1"}, "alternative-id": ["10.1021/ef000085p"], "URL": "http://dx.doi.org/10.1021/ef000085p", "ISSN": ["0887-0624", "1520-5029"], "issn-type": [{"value": "0887-0624", "type": "print"}, {"value": "1520-5029", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 10, 10]], "date-time": "2018-10-10T18:40:36Z", "timestamp": 1539196836953}, "reference-count": 28, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 2, 1]], "date-time": "2014-02-01T00:00:00Z", "timestamp": 1391212800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Waste Management"], "published-print": {"date-parts": [[2014, 2]]}, "DOI": "10.1016/j.wasman.2013.10.036", "type": "journal-article", "created": {"date-parts": [[2013, 11, 16]], "date-time": "2013-11-16T21:30:33Z", "timestamp": 1384637433000}, "page": "504-512", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 15, "title": ["The effect of clay catalyst on the chemical composition of bio-oil obtained by co-pyrolysis of cellulose and polyethylene"], "prefix": "10.1016", "volume": "34", "author": [{"given": "Agnieszka", "family": "Solak", "sequence": "first", "affiliation": []}, {"given": "Piotr", "family": "Rutkowski", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Waste Management"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0956053X13005229?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0956053X13005229?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 10]], "date-time": "2018-10-10T18:20:52Z", "timestamp": 1539195652000}, "score": 21.802963, "issued": {"date-parts": [[2014, 2]]}, "references-count": 28, "journal-issue": {"published-print": {"date-parts": [[2014, 2]]}, "issue": "2"}, "alternative-id": ["S0956053X13005229"], "URL": "http://dx.doi.org/10.1016/j.wasman.2013.10.036", "ISSN": ["0956-053X"], "issn-type": [{"value": "0956-053X", "type": "print"}], "subject": ["Waste Management and Disposal"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "The effect of clay catalyst on the chemical composition of bio-oil obtained by co-pyrolysis of cellulose and polyethylene", "name": "articletitle", "label": "Article Title"}, {"value": "Waste Management", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.wasman.2013.10.036", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2018, 11, 9]], "date-time": "2018-11-09T23:22:35Z", "timestamp": 1541805755118}, "reference-count": 130, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2016, 10, 1]], "date-time": "2016-10-01T00:00:00Z", "timestamp": 1475280000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "theclinics.com", "clinicalkey.com.au", "clinicalkey.fr", "surgonc.theclinics.com", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Surgical Oncology Clinics of North America"], "published-print": {"date-parts": [[2016, 10]]}, "DOI": "10.1016/j.soc.2016.05.006", "type": "journal-article", "created": {"date-parts": [[2016, 8, 4]], "date-time": "2016-08-04T17:36:03Z", "timestamp": 1470332163000}, "page": "735-759", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Combined Therapy of Gastrointestinal Stromal Tumors"], "prefix": "10.1016", "volume": "25", "author": [{"given": "Piotr", "family": "Rutkowski", "sequence": "first", "affiliation": []}, {"given": "Daphne", "family": "Hompes", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Surgical Oncology Clinics of North America"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1055320716300199?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1055320716300199?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 9]], "date-time": "2018-09-09T12:54:20Z", "timestamp": 1536497660000}, "score": 21.802963, "issued": {"date-parts": [[2016, 10]]}, "references-count": 130, "journal-issue": {"published-print": {"date-parts": [[2016, 10]]}, "issue": "4"}, "alternative-id": ["S1055320716300199"], "URL": "http://dx.doi.org/10.1016/j.soc.2016.05.006", "ISSN": ["1055-3207"], "issn-type": [{"value": "1055-3207", "type": "print"}], "subject": ["Surgery", "Oncology"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Combined Therapy of Gastrointestinal Stromal Tumors", "name": "articletitle", "label": "Article Title"}, {"value": "Surgical Oncology Clinics of North America", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.soc.2016.05.006", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2016 Elsevier Inc. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T15:49:15Z", "timestamp": 1525794555346}, "reference-count": 27, "publisher": "Springer Nature", "issue": "2", "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["memo"], "published-print": {"date-parts": [[2014, 5]]}, "DOI": "10.1007/s12254-014-0146-8", "type": "journal-article", "created": {"date-parts": [[2014, 6, 12]], "date-time": "2014-06-12T07:00:23Z", "timestamp": 1402556423000}, "page": "92-96", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Follow-up in soft tissue sarcomas"], "prefix": "10.1007", "volume": "7", "author": [{"given": "Piotr", "family": "Rutkowski", "sequence": "first", "affiliation": []}, {"given": "Iwona", "family": "\u0141ugowska", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2014, 6, 13]]}, "reference": [{"key": "146_CR1", "doi-asserted-by": "crossref", "first-page": "1020", "DOI": "10.1016/j.ejso.2005.07.015", "volume": "31", "author": "P Cool", "year": "2005", "unstructured": "Cool P, Grimer R, Rees R. Surveillance in patients with sarcoma of the extremities. Eur J Surg Oncol. 2005;31:1020\u20134.", "journal-title": "Eur J Surg Oncol"}, {"key": "146_CR2", "unstructured": "National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Soft Tissue Sarcomas, Version 1.2013."}, {"key": "146_CR3", "first-page": "506182", "volume": "2010", "author": "R Grimer", "year": "2010", "unstructured": "Grimer R, Judson I, Peake D, Seddon B. Guidelines for the management of soft tissue sarcomas. Sarcoma. 2010;2010:506182.", "journal-title": "Sarcoma."}, {"issue": "2", "key": "146_CR4", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1002/jso.23060", "volume": "106", "author": "YS Chou", "year": "2012", "unstructured": "Chou YS, Liu CY, Chen WM, Chen TH, Chen PC, Wu HT, Chiou HJ, Shiau CY, Wu YC, Liu CL, Chao TC, Tzeng CH, Yen CC. Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease-specific survival. J Surg Oncol. 2012;106(2):155\u201361.", "journal-title": "J Surg Oncol"}, {"key": "146_CR5", "first-page": "55", "volume": "60", "author": "W Ruka", "year": "2010", "unstructured": "Ruka W, Rutkowski P, Krzakowski M, Grzesiakowska U, Ptaszy\u0144ski K, Jeziorski A, Polkowski W, Ry\u015b J, S\u0142uszniak J, Dziewirski W, Morysi\u0144ski T, \u015awitaj T, B\u0119benek M, Siedlecki JA, Limon J, Nowecki ZI. Soft tissue sarcomas in adult patients \u2013guidelines for diagnosis and treatment. Nowotwory \u2013 Journal of Oncology. 2010;60:55\u201365.", "journal-title": "Nowotwory \u2013 Journal of Oncology"}, {"key": "146_CR6", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1002/(SICI)1097-0142(19960215)77:4<675::AID-CNCR13>3.0.CO;2-Y", "volume": "77", "author": "AN Van Geel", "year": "1996", "unstructured": "Van Geel AN, Pastorini U, Jauch KW, Judson IR, van Coevorden F, Buesa JM, Nielsen OS, Boudinet A, Tursz T, Schmitz PIM. The surgical treatment of lung metastases. The European organization for research and treatment of cancer\u2014soft tissue and bone sarcoma group study of 255 patients. Cancer. 1996;77:675\u201382.", "journal-title": "Cancer."}, {"key": "146_CR7", "doi-asserted-by": "crossref", "first-page": "413", "DOI": "10.1016/S0093-7754(03)00101-5", "volume": "30", "author": "SR Patel", "year": "2003", "unstructured": "Patel SR, Zagars GK, Pisters PWT. The follow-up of adult soft tissue sarcomas. Sem Surg Oncol. 2003;30:413\u20136.", "journal-title": "Sem Surg Oncol"}, {"key": "146_CR8", "doi-asserted-by": "crossref", "first-page": "662", "DOI": "10.1002/1097-0142(19920201)69:3<662::AID-CNCR2820690311>3.0.CO;2-I", "volume": "69", "author": "AG Casson", "year": "1992", "unstructured": "Casson AG, Putnam JB, Natarajan G, Johnston DA, Mountain C, McMurtrey M, Roth JA. Five-years survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer. 1992;69:662\u20138.", "journal-title": "Cancer"}, {"key": "146_CR9", "doi-asserted-by": "crossref", "first-page": "705", "DOI": "10.1097/00000658-199312000-00002", "volume": "218", "author": "MA Gadd", "year": "1993", "unstructured": "Gadd MA, Casper ES, Woodruff JM, et al. Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma. Ann Surg. 1993;218:705\u201312.", "journal-title": "Ann Surg"}, {"key": "146_CR10", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1007/s10434-000-0009-x", "volume": "7", "author": "BP Whooley", "year": "2000", "unstructured": "Whooley BP, Gibbs JF, Mooney MM, et al. Primary extremity sarcoma: What is the appropriate follow-up? Ann Surg Oncol. 2000;7:9\u201314.", "journal-title": "Ann Surg Oncol"}, {"key": "146_CR11", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1002/(SICI)1098-2388(199907/08)17:1<83::AID-SSU11>3.0.CO;2-W", "volume": "17", "author": "BP Whooley", "year": "1999", "unstructured": "Whooley BP, Mooney MM, Gibbs JF, Kraybill WG. Effective follow-up strategies in soft tissue sarcoma. Sem Surg Oncol. 1999;17:83\u20137.", "journal-title": "Sem Surg Oncol."}, {"issue": "2", "key": "146_CR12", "doi-asserted-by": "crossref", "first-page": "353", "DOI": "10.2214/ajr.157.2.1853821", "volume": "157", "author": "H Choi", "year": "1991", "unstructured": "Choi H, Varma DG, Fornage BD, Kim EE, Johnston DA. Soft-tissue sarcoma: MR imaging vs sonography for detection of local recurrence after surgery. AJR Am J Roentgenol. 1991;157(2):353\u20138.", "journal-title": "AJR Am J Roentgenol"}, {"issue": "3", "key": "146_CR13", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1053/crad.1999.0343", "volume": "5", "author": "S Arya", "year": "2000", "unstructured": "Arya S, Nagarkatti DG, Dudhat SB, Nadkarni KS, Joshi MS, Shinde SR. Soft tissue sarcomas: ultrasonographic evaluation of local recurrences. Clin Radiol. 2000;55(3):193\u20137.", "journal-title": "Clin Radiol"}, {"issue": "2", "key": "146_CR14", "first-page": "157", "volume": "2", "author": "A Briccoli", "year": "2007", "unstructured": "Briccoli A, Galletti S, Salone M, Morganti A, Pelotti P, Rocca M. Ultrasonography is superior to computed tomography and magnetic resonance imaging in determining superficial resection margins of malignant chest wall tumors. J Ultrasound Med. 2007;26(2):157\u201362.", "journal-title": "J Ultrasound Med"}, {"key": "146_CR15", "doi-asserted-by": "crossref", "first-page": "50", "DOI": "10.1016/j.ejrad.2009.05.027", "volume": "72", "author": "D Labarre", "year": "2009", "unstructured": "Labarre D, Aziza R, Filleron T, Delannes M, Delaunay F, Marques B, Ferron G, Chevreau C. Detection of local recurrences of limb soft tissue sarcomas: Is magnetic resonance imaging (MRI) relevant? Eur J Radiol. 2009;72:50\u20133.", "journal-title": "Eur J Radiol"}, {"key": "146_CR16", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1148/radiology.190.1.8259417", "volume": "190", "author": "D Vanel", "year": "1994", "unstructured": "Vanel D, Shapeero LG, De Baere T, et al. MR imaging in the follow-up of malignant and aggressive soft-tissue tumors: results of 511 examinations. Radiology 1994;190:263\u20138.", "journal-title": "Radiology"}, {"issue": "Suppl.", "key": "146_CR17", "first-page": "vii92", "volume": "23", "author": "The ESMO/European Sarcoma Network Working Group", "year": "2012", "unstructured": "The ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2012;23(Suppl.\u00a07):vii92\u20139.", "journal-title": "Ann. Oncol"}, {"key": "146_CR18", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1007/s10434-000-0002-4", "volume": "7", "author": "MF. Brennan", "year": "2000", "unstructured": "Brennan MF. Follow-up is valuable and effective: true, true and unrelated? Ann Surg Oncol. 2000;7:2\u20133.", "journal-title": "Ann Surg Oncol"}, {"issue": "suppl.", "key": "146_CR19", "first-page": "64", "volume": "20", "author": "PG Casali", "year": "2009", "unstructured": "Casali PG, Jost L, Reichardt P, et al. Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann. Oncol. 2009;20(suppl.\u00a04):64\u20137.", "journal-title": "Ann. Oncol"}, {"key": "146_CR20", "first-page": "181", "volume": "6", "author": "P Rutkowski", "year": "2010", "unstructured": "Rutkowski P, Kulig J, Krzakowski M, et al. Recommendations for diagnostics and therapy of gastrointestinal stromal tumors (GIST) in 2010. Onkol. Prakt. Klin. 2010;6:181\u201394.", "journal-title": "Onkol. Prakt. Klin"}, {"key": "146_CR21", "doi-asserted-by": "crossref", "first-page": "34128", "DOI": "10.1155/2007/34128", "volume": "2007", "author": "CH Gerrand", "year": "2007", "unstructured": "Gerrand CH, Billingham LJ, Woll PJ, Grimer RJ. Follow-up after primary treatment of soft tissue sarcoma: a survey of current practice in the United Kingdom. Sarcoma. 2007;2007:34128.", "journal-title": "Sarcoma"}, {"key": "146_CR22", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1006/jsre.2002.6544", "volume": "108", "author": "K Sakata", "year": "2002", "unstructured": "Sakata K, Beitler AL, Gibbs JF, Kraybill WG, Virgo KS, Johnson FE. How surgeon age affects surveillance strategies for extremity soft tissue sarcoma patients after potentially curative treatment. J Surg Res. 2002;108:227\u201334.", "journal-title": "J Surg Res"}, {"key": "146_CR23", "doi-asserted-by": "crossref", "first-page": "1568", "DOI": "10.1007/s11999-013-3385-9", "volume": "472", "author": "A Puri", "year": "2014", "unstructured": "Puri A, Gulia A, Hawaldar R, Ranganathan P, Badwe RA. Does intensity of surveillance affect survival after surgery for sarcomas? Results of a randomized noninferiority trial. Clin Orthop Relat Res. 2014;472:1568\u201375.", "journal-title": "Clin Orthop Relat Res"}, {"issue": "21", "key": "146_CR24", "doi-asserted-by": "crossref", "first-page": "4916", "DOI": "10.1002/cncr.26079", "volume": "117", "author": "P Rutkowski", "year": "2011", "unstructured": "Rutkowski P, Wozniak A, D\u0119biec-Rychter M, K\u0105kol M, Dziewirski W, Zdzienicki M, Ptaszynski K, Jurkowska M, Limon J, Siedlecki JA. Clinical utility of the new American Joint Committee on cancer staging system for gastrointestinal stromal tumors: Current overall survival after primary tumor resection. Cancer. 2011;117(21):4916\u201324.", "journal-title": "Cancer."}, {"key": "146_CR25", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1586/era.09.171", "volume": "10", "author": "P Reichardt", "year": "2010", "unstructured": "Reichardt P, Blay JY, von Mehren M. Towards global consensus in the treatment of gastrointestinal stromal tumor. Expert Rev Anticancer Ther. 2010;10:221\u201332.", "journal-title": "Expert Rev Anticancer Ther"}, {"issue": "12", "key": "146_CR26", "doi-asserted-by": "crossref", "first-page": "1265", "DOI": "10.1001/jama.2012.347", "volume": "307", "author": "H. Joensuu", "year": "2012", "unstructured": "Joensuu H., Eriksson M., Sundby Hall K, Hartmann JT, Pink D, Sch\u00fctte J, Ramadori G, Hohenberger P, Duyster J, Al-Batran SE, Schlemmer M, Bauer S, Wardelmann E, Sarlomo-Rikala M, Nilsson B, Sihto H, Monge OR, Bono P, Kallio R, Vehtari A, Leinonen M, Alveg\u00e5rd T, Reichardt P. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA. 2012;307(12):1265\u201372.", "journal-title": "JAMA."}, {"key": "146_CR27", "first-page": "429", "volume": "25", "author": "A Goel", "year": "2004", "unstructured": "Goel A, Christy M, Virgo K, Kraybill W, Johnson F. Costs of follow-up after potentially curative treatment for extremity soft-tissue sarcoma. Int J Oncol. 2004;25:429\u201335.", "journal-title": "Int J Oncol"}], "container-title": ["memo - Magazine of European Medical Oncology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s12254-014-0146-8", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 22]], "date-time": "2017-06-22T14:44:49Z", "timestamp": 1498142689000}, "score": 21.802963, "issued": {"date-parts": [[2014, 5]]}, "references-count": 27, "journal-issue": {"published-print": {"date-parts": [[2014, 5]]}, "issue": "2"}, "alternative-id": ["146"], "URL": "http://dx.doi.org/10.1007/s12254-014-0146-8", "relation": {"cites": []}, "ISSN": ["1865-5041", "1865-5076"], "issn-type": [{"value": "1865-5041", "type": "print"}, {"value": "1865-5076", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 9]], "date-time": "2018-05-09T09:47:12Z", "timestamp": 1525859232907}, "reference-count": 11, "publisher": "Springer Nature", "issue": "1", "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["BMC Med"], "published-print": {"date-parts": [[2017, 12]]}, "DOI": "10.1186/s12916-017-0826-4", "type": "journal-article", "created": {"date-parts": [[2017, 3, 1]], "date-time": "2017-03-01T17:44:45Z", "timestamp": 1488390285000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 4, "title": ["News from the melanoma sessions of the European Cancer Congress 2017"], "prefix": "10.1186", "volume": "15", "author": [{"given": "Piotr", "family": "Rutkowski", "sequence": "first", "affiliation": []}, {"given": "Katarzyna", "family": "Kozak", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2017, 3, 17]]}, "reference": [{"issue": "Suppl 1", "key": "826_CR1", "doi-asserted-by": "publisher", "first-page": "S123", "DOI": "10.1016/S0959-8049(17)30484-7", "volume": "72", "author": "P Autier", "year": "2017", "unstructured": "Autier P, Koechlin A, Boniol M. 1144 \u2013 Prediction of numbers of melanoma deaths by 2050. Eur J Cancer. 2017;72 Suppl 1:S123\u20134. doi: 10.1016/S0959-8049(17)30484-7 .", "journal-title": "Eur J Cancer"}, {"issue": "3", "key": "826_CR2", "doi-asserted-by": "publisher", "first-page": "513", "DOI": "10.1016/j.ejso.2016.12.001", "volume": "43", "author": "P Rutkowski", "year": "2016", "unstructured": "Rutkowski P. Introduction to the special issue of European Journal of Surgical Oncology: New roads in melanoma management. Eur J Surg Oncol. 2016;43(3):513\u20136. doi: 10.1016/j.ejso.2016.12.001 .", "journal-title": "Eur J Surg Oncol"}, {"key": "826_CR3", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1016/j.ejca.2016.05.005", "volume": "63", "author": "C Garbe", "year": "2016", "unstructured": "Garbe C, Peris K, Hauschild A, Saiag P, Middleton M, et al. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016. Eur J Cancer. 2016;63:201\u201317.", "journal-title": "Eur J Cancer"}, {"key": "826_CR4", "unstructured": "NCCN Guidelines. Melanoma. Version 2.2017. https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#melanoma . Accessed Feb 2017."}, {"key": "826_CR5", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1016/j.ejca.2015.09.013", "volume": "53", "author": "S Ugurel", "year": "2016", "unstructured": "Ugurel S, Roehmel J, Ascierto PA, Flaherty KT, Grob JJ, Hauschild A, Larkin J, Long GV, Lorigan P, McArthur GA, Ribas A, Robert C, Schadendorf D, Garbe C. Survival of patient s with advanced metastatic melanoma: The impact of novel therapies. Eur J Cancer. 2016;53:125\u201334.", "journal-title": "Eur J Cancer"}, {"issue": "19", "key": "826_CR6", "doi-asserted-by": "crossref", "first-page": "1845", "DOI": "10.1056/NEJMoa1611299", "volume": "375", "author": "AM Eggermont", "year": "2016", "unstructured": "Eggermont AM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H, Hamid O, Robert C, Ascierto PA, Richards JM, Lebb\u00e9 C, Ferraresi V, Smylie M, Weber JS, Maio M, Bastholt L, Mortier L, Thomas L, Tahir S, Hauschild A, Hassel JC, Hodi FS, Taitt C, de Pril V, de Schaetzen G, Suciu S, Testori A. Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy. N Engl J Med. 2016;375(19):1845\u201355.", "journal-title": "N Engl J Med"}, {"issue": "Suppl 1", "key": "826_CR7", "doi-asserted-by": "publisher", "first-page": "S124", "DOI": "10.1016/S0959-8049(17)30485-9", "volume": "72", "author": "J Haanen", "year": "2017", "unstructured": "Haanen J, Blank C, van Thienen H, Mallo H, Adriaansz S, ter Meulen S, Madu M, Pronk L, van der Hiel L, van de Wiel B, Peeper D, van Akkooi A. 1146 \u2013 Downsizing of locally advanced stage III (bulky) BRAF V600E/K melanoma with combination targeted therapy to achieve R0 resection. Eur J Cancer. 2017;72 Suppl 1:S124. doi: 10.1016/S0959-8049(17)30485-9 .", "journal-title": "Eur J Cancer"}, {"key": "826_CR8", "unstructured": "Amaria R. Treatment with neoadjuvant and adjuvant BRAF and MEK inhibitors is associated with improved relapse-free survival over standard-of-care therapy in patients with high risk resectable BRAF-mutant melanoma. Presentation at ECCO 2017. http://www.eccocongress.org/Scientific-Programme/Searchable-Programme . Accessed Feb 2017."}, {"key": "826_CR9", "unstructured": "Long G. Neoadjuvant therapy in bulky stage III melanoma: Are we there yet? Presentation at ECCO. 2017. http://www.eccocongress.org/Scientific-Programme/Searchable-Programme . Accessed Feb 2017."}, {"issue": "Suppl 1", "key": "826_CR10", "doi-asserted-by": "publisher", "first-page": "S122", "DOI": "10.1016/S0959-8049(17)30482-3", "volume": "72", "author": "GV Long", "year": "2017", "unstructured": "Long GV, Blank C, Ribas A, Mortier L, Carlino MS, Lotem M, Lorigan P, Neyns B, Petrella TM, Puzanov I, Richtig E, O'Day SJ, Masucci G, Lebbe C, Steven N, Lutzky J, Hille D, Ebbinghaus S, Ibrahim N, McNeil C. 1141 \u2013 Impact of baseline serum lactate dehydrogenase concentration on the efficacy of pembrolizumab and ipilimumab in patients with advanced melanoma: data from KEYNOTE-006. Eur J Cancer. 2017;72 Suppl 1:S122\u20133. doi: 10.1016/S0959-8049(17)30482-3 .", "journal-title": "Eur J Cancer"}, {"issue": "Suppl 1", "key": "826_CR11", "doi-asserted-by": "publisher", "first-page": "S123", "DOI": "10.1016/S0959-8049(17)30483-5", "volume": "72", "author": "M Butler", "year": "2017", "unstructured": "Butler M, Hamid O, Ribas A, Hodi FS, Walpole E, Dauad A, Arance A, Brown E, Hoeller C, Mortier L, Schachter J, Long J, Ebbinghaus S, Ibrahim N, Robert C. 1142 \u2013 Efficacy of pembrolizumab in patients with advanced mucosal melanoma enrolled in the KEYNOTE-001, 002, and 006 studies. Eur J Cancer. 2017;72 Suppl 1:S123. doi: 10.1016/S0959-8049(17)30483-5 .", "journal-title": "Eur J Cancer"}], "container-title": ["BMC Medicine"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/s12916-017-0826-4.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 25]], "date-time": "2017-06-25T11:41:04Z", "timestamp": 1498390864000}, "score": 21.802963, "issued": {"date-parts": [[2017, 3, 17]]}, "references-count": 11, "journal-issue": {"published-print": {"date-parts": [[2017, 12]]}, "issue": "1"}, "alternative-id": ["826"], "URL": "http://dx.doi.org/10.1186/s12916-017-0826-4", "relation": {"cites": []}, "ISSN": ["1741-7015"], "issn-type": [{"value": "1741-7015", "type": "electronic"}], "article-number": "57"}, {"indexed": {"date-parts": [[2018, 7, 11]], "date-time": "2018-07-11T10:42:36Z", "timestamp": 1531305756454}, "reference-count": 51, "publisher": "Informa Healthcare", "issue": "9", "content-domain": {"domain": ["www.tandfonline.com"], "crossmark-restriction": true}, "short-container-title": ["Expert Opinion on Drug Safety"], "published-print": {"date-parts": [[2014, 9]]}, "DOI": "10.1517/14740338.2014.939954", "type": "journal-article", "created": {"date-parts": [[2014, 7, 11]], "date-time": "2014-07-11T13:36:21Z", "timestamp": 1405085781000}, "page": "1249-1258", "update-policy": "http://dx.doi.org/10.1080/tandf_crossmark_01", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Dabrafenib for the treatment ofBRAFV600-positive melanoma: a safety evaluation"], "prefix": "10.1517", "volume": "13", "author": [{"given": "Piotr", "family": "Rutkowski", "sequence": "first", "affiliation": []}, {"given": "Christian", "family": "Blank", "sequence": "additional", "affiliation": []}], "member": "3197", "published-online": {"date-parts": [[2014, 7, 11]]}, "reference": [{"key": "CIT0001", "DOI": "10.1038/nature00766", "doi-asserted-by": "publisher"}, {"key": "CIT0002", "DOI": "10.1056/NEJMoa050092", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "DOI": "10.1016/j.bcp.2010.03.019", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "DOI": "10.1007/s10555-005-5865-1", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "DOI": "10.1200/JCO.2006.06.2984", "doi-asserted-by": "publisher"}, {"issue": "1", "key": "CIT0006", "first-page": "47", "volume": "8", "author": "Rutkowski P", "year": "2014", "journal-title": "Oncol Lett"}, {"key": "CIT0007", "DOI": "10.1097/00000372-200310000-00001", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "DOI": "10.1093/jnci/djg123", "doi-asserted-by": "publisher"}, {"key": "CIT0009", "DOI": "10.1016/S0092-8674(04)00215-6", "doi-asserted-by": "publisher"}, {"key": "CIT0010", "DOI": "10.1016/j.hoc.2009.04.001", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1038/nature03890", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.1038/ng1054", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "DOI": "10.1200/JCO.2007.12.7837", "doi-asserted-by": "publisher"}, {"key": "CIT0014", "DOI": "10.1056/NEJMoa1103782", "doi-asserted-by": "publisher"}, {"key": "CIT0015", "DOI": "10.1016/S0140-6736(12)60868-X", "doi-asserted-by": "publisher"}, {"key": "CIT0016", "DOI": "10.1016/S1470-2045(12)70431-X", "doi-asserted-by": "publisher"}, {"key": "CIT0017", "DOI": "10.1111/j.1755-148X.2012.00981.x", "doi-asserted-by": "publisher"}, {"key": "CIT0018", "DOI": "10.1016/S1470-2045(14)70012-9", "doi-asserted-by": "publisher"}, {"key": "CIT0019", "DOI": "10.1200/JCO.2010.32.4327", "doi-asserted-by": "publisher"}, {"key": "CIT0020", "DOI": "10.1586/era.13.24", "doi-asserted-by": "publisher"}, {"key": "CIT0021", "DOI": "10.1016/S1470-2045(14)70051-8", "doi-asserted-by": "publisher"}, {"key": "CIT0023", "DOI": "10.1016/S0140-6736(12)60398-5", "doi-asserted-by": "publisher"}, {"key": "CIT0024", "DOI": "10.1002/jcph.263", "doi-asserted-by": "publisher"}, {"key": "CIT0025", "DOI": "10.1002/jps.23519", "doi-asserted-by": "publisher"}, {"key": "CIT0026", "DOI": "10.1200/JCO.2013.49.8691", "doi-asserted-by": "publisher"}, {"key": "CIT0027", "DOI": "10.1158/2159-8290.CD-13-0631", "doi-asserted-by": "publisher"}, {"key": "CIT0028", "DOI": "10.1056/NEJMoa1210093", "doi-asserted-by": "publisher"}, {"key": "CIT0029", "DOI": "10.1371/journal.pone.0067583", "doi-asserted-by": "publisher"}, {"key": "CIT0030", "DOI": "10.1056/NEJMoa1203421", "doi-asserted-by": "publisher"}, {"key": "CIT0031", "DOI": "10.1007/s11912-011-0198-4", "doi-asserted-by": "publisher"}, {"key": "CIT0032", "DOI": "10.1056/NEJMoa1105358", "doi-asserted-by": "publisher"}, {"key": "CIT0033", "DOI": "10.1158/1078-0432.CCR-09-1883", "doi-asserted-by": "publisher"}, {"key": "CIT0034", "author": "Vanneste L", "year": "2014", "journal-title": "J Eur Acad Dermatol Venereol"}, {"key": "CIT0035", "DOI": "10.1111/bjd.12010", "doi-asserted-by": "publisher"}, {"key": "CIT0036", "DOI": "10.1016/j.cell.2009.12.040", "doi-asserted-by": "publisher"}, {"key": "CIT0037", "DOI": "10.1038/nature08833", "doi-asserted-by": "publisher"}, {"key": "CIT0038", "DOI": "10.1093/annonc/mds292", "doi-asserted-by": "publisher"}, {"key": "CIT0039", "DOI": "10.1111/j.1365-2133.2012.11155.x", "doi-asserted-by": "publisher"}, {"key": "CIT0040", "DOI": "10.1111/j.1755-148X.2012.01031.x", "doi-asserted-by": "publisher"}, {"key": "CIT0041", "DOI": "10.1200/JCO.2012.44.4265", "doi-asserted-by": "publisher"}, {"key": "CIT0042", "DOI": "10.1158/1078-0432.CCR-13-2054", "doi-asserted-by": "publisher"}, {"key": "CIT0043", "DOI": "10.1038/nrclinonc.2013.83", "doi-asserted-by": "publisher"}, {"key": "CIT0044", "DOI": "10.1517/17425255.2013.794220", "doi-asserted-by": "publisher"}, {"key": "CIT0045", "author": "Chapman P", "volume": "25", "first-page": "847", "year": "2012", "journal-title": "Pigment Cell Melanoma Res"}, {"key": "CIT0046", "DOI": "10.1200/JCO.2011.41.1660", "doi-asserted-by": "publisher"}, {"key": "CIT0047", "DOI": "10.1056/NEJMoa1208958", "doi-asserted-by": "publisher"}, {"key": "CIT0048", "author": "Carlino MS", "year": "2014", "journal-title": "J Clin Oncol"}, {"key": "CIT0049", "DOI": "10.1056/NEJMc1113752", "doi-asserted-by": "publisher"}, {"key": "CIT0050", "DOI": "10.1111/pcmr.12132", "doi-asserted-by": "publisher"}, {"issue": "5", "key": "CIT0051", "first-page": "abstract 9034", "volume": "32", "author": "Ascierto PA", "year": "2014", "journal-title": "J Clin Oncol"}, {"issue": "5", "key": "CIT0052", "first-page": "abstract 9011", "volume": "32", "author": "Long GV", "year": "2014", "journal-title": "J Clin Oncol"}], "container-title": ["Expert Opinion on Drug Safety"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1517/14740338.2014.939954", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 13]], "date-time": "2016-12-13T14:01:01Z", "timestamp": 1481637661000}, "score": 21.802963, "issued": {"date-parts": [[2014, 7, 11]]}, "references-count": 51, "journal-issue": {"published-online": {"date-parts": [[2014, 7, 5]]}, "published-print": {"date-parts": [[2014, 9]]}, "issue": "9"}, "alternative-id": ["10.1517/14740338.2014.939954"], "URL": "http://dx.doi.org/10.1517/14740338.2014.939954", "relation": {"cites": []}, "ISSN": ["1474-0338", "1744-764X"], "issn-type": [{"value": "1474-0338", "type": "print"}, {"value": "1744-764X", "type": "electronic"}], "assertion": [{"value": "The publishing and review policy for this title is described in its Aims & Scope.", "order": 1, "name": "peerreview_statement", "label": "Peer Review Statement"}, {"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ieds20", "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ieds20", "order": 2, "name": "aims_and_scope_url", "label": "Aim & Scope"}]}, {"indexed": {"date-parts": [[2018, 12, 22]], "date-time": "2018-12-22T05:10:43Z", "timestamp": 1545455443528}, "reference-count": 69, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 2, 1]], "date-time": "2009-02-01T00:00:00Z", "timestamp": 1233446400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Lancet Oncology"], "published-print": {"date-parts": [[2009, 2]]}, "DOI": "10.1016/s1470-2045(09)70017-8", "type": "journal-article", "created": {"date-parts": [[2009, 1, 30]], "date-time": "2009-01-30T10:19:10Z", "timestamp": 1233310750000}, "page": "157-163", "source": "Crossref", "is-referenced-by-count": 34, "title": ["Emergency surgery in the era of molecular treatment of solid tumours"], "prefix": "10.1016", "volume": "10", "author": [{"given": "Piotr", "family": "Rutkowski", "sequence": "first", "affiliation": []}, {"given": "W\u0142odzimierz", "family": "Ruka", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["The Lancet Oncology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1470204509700178?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1470204509700178?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 22]], "date-time": "2018-12-22T04:50:11Z", "timestamp": 1545454211000}, "score": 21.802963, "issued": {"date-parts": [[2009, 2]]}, "references-count": 69, "journal-issue": {"published-print": {"date-parts": [[2009, 2]]}, "issue": "2"}, "alternative-id": ["S1470204509700178"], "URL": "http://dx.doi.org/10.1016/s1470-2045(09)70017-8", "ISSN": ["1470-2045"], "issn-type": [{"value": "1470-2045", "type": "print"}], "subject": ["Oncology"]}, {"indexed": {"date-parts": [[2018, 9, 9]], "date-time": "2018-09-09T16:40:10Z", "timestamp": 1536511210735}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2016, 6, 1]], "date-time": "2016-06-01T00:00:00Z", "timestamp": 1464739200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "transplantation-proceedings.org", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.fr", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Transplantation Proceedings"], "published-print": {"date-parts": [[2016, 6]]}, "DOI": "10.1016/j.transproceed.2016.07.002", "type": "journal-article", "created": {"date-parts": [[2016, 8, 3]], "date-time": "2016-08-03T23:49:39Z", "timestamp": 1470268179000}, "page": "1331", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Preface"], "prefix": "10.1016", "volume": "48", "author": [{"given": "Boles\u0142aw", "family": "Rutkowski", "sequence": "first", "affiliation": []}, {"given": "Piotr", "family": "Przybylowski", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Transplantation Proceedings"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0041134516303323?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0041134516303323?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 9]], "date-time": "2018-09-09T16:21:07Z", "timestamp": 1536510067000}, "score": 21.802963, "issued": {"date-parts": [[2016, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2016, 6]]}, "issue": "5"}, "alternative-id": ["S0041134516303323"], "URL": "http://dx.doi.org/10.1016/j.transproceed.2016.07.002", "ISSN": ["0041-1345"], "issn-type": [{"value": "0041-1345", "type": "print"}], "subject": ["Surgery", "Transplantation"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Preface", "name": "articletitle", "label": "Article Title"}, {"value": "Transplantation Proceedings", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.transproceed.2016.07.002", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "simple-article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2016 Elsevier Inc. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2018, 11, 12]], "date-time": "2018-11-12T08:10:01Z", "timestamp": 1542010201594}, "reference-count": 0, "publisher": "AME Publishing Company", "issue": "S4", "content-domain": {"domain": ["amegroups.com"], "crossmark-restriction": false}, "short-container-title": ["Transl. Cancer Res"], "published-print": {"date-parts": [[2016, 10]]}, "DOI": "10.21037/tcr.2016.10.36", "type": "journal-article", "created": {"date-parts": [[2016, 11, 7]], "date-time": "2016-11-07T09:38:46Z", "timestamp": 1478511526000}, "page": "S858-S861", "update-policy": "http://dx.doi.org/10.21037/ame_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Perspective towards the clinical application of eribulin in soft tissue sarcomas"], "prefix": "10.21037", "volume": "5", "author": [{"given": "Piotr", "family": "Rutkowski", "sequence": "first", "affiliation": []}, {"given": "Iwona", "family": "Lugowska", "sequence": "additional", "affiliation": []}], "member": "8611", "published-online": {"date-parts": [[2016, 10]]}, "container-title": ["Translational Cancer Research"], "link": [{"URL": "http://tcr.amegroups.com/article/download/10159/8724", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 12]], "date-time": "2018-11-12T07:29:52Z", "timestamp": 1542007792000}, "score": 21.802963, "issued": {"date-parts": [[2016, 10]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016, 10]]}, "published-print": {"date-parts": [[2016, 10]]}, "issue": "S4"}, "URL": "http://dx.doi.org/10.21037/tcr.2016.10.36", "ISSN": ["2218-676X", "2219-6803"], "issn-type": [{"value": "2218-676X", "type": "print"}, {"value": "2219-6803", "type": "electronic"}], "subject": ["Cancer Research", "Oncology", "Radiology Nuclear Medicine and imaging"]}, {"indexed": {"date-parts": [[2018, 12, 14]], "date-time": "2018-12-14T08:11:34Z", "timestamp": 1544775094717}, "reference-count": 83, "publisher": "Springer Nature", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2018, 12, 14]], "date-time": "2018-12-14T00:00:00Z", "timestamp": 1544745600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Virchows Arch"], "DOI": "10.1007/s00428-018-2506-y", "type": "journal-article", "created": {"date-parts": [[2018, 12, 14]], "date-time": "2018-12-14T07:39:36Z", "timestamp": 1544773176000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Rational combination of cancer immunotherapy in melanoma"], "prefix": "10.1007", "author": [{"given": "Mario", "family": "Mandal\u00e0", "sequence": "first", "affiliation": []}, {"given": "Piotr", "family": "Rutkowski", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 12, 14]]}, "reference": [{"key": "2506_CR1", "doi-asserted-by": "crossref", "first-page": "463", "DOI": "10.1038/nrclinonc.2017.43", "volume": "14", "author": "JJ Luke", "year": "2017", "unstructured": "Luke JJ, Flaherty KT, Ribas A, Long GV (2017) Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat Rev Clin Oncol 14:463\u2013482", "journal-title": "Nat Rev Clin Oncol"}, {"key": "2506_CR2", "unstructured": "Mandal\u00e0, M., Tondini, C., Merelli, B and Daniela Massi. Rationale for new checkpoint inhibitor combinations in melanoma. Am J Clin Dermatol 2017; 18: 597\u2013611", "DOI": "10.1007/s40257-017-0282-0", "doi-asserted-by": "crossref"}, {"key": "2506_CR3", "doi-asserted-by": "crossref", "first-page": "949", "DOI": "10.1038/nature00766", "volume": "417", "author": "H Davies", "year": "2002", "unstructured": "Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JWC, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA (2002) Mutations of the BRAF gene in human cancer. Nature 417:949\u2013954", "journal-title": "Nature"}, {"key": "2506_CR4", "doi-asserted-by": "crossref", "first-page": "358", "DOI": "10.1016/S0140-6736(12)60868-X", "volume": "380", "author": "A Hauschild", "year": "2012", "unstructured": "Hauschild A, Grob JJ, Demidov LV, Jouary T, Gutzmer R, Millward M, Rutkowski P, Blank CU, Miller WH Jr, Kaempgen E, Mart\u00edn-Algarra S, Karaszewska B, Mauch C, Chiarion-Sileni V, Martin AM, Swann S, Haney P, Mirakhur B, Guckert ME, Goodman V, Chapman PB (2012) Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial. Lancet 380:358\u2013365", "journal-title": "Lancet"}, {"key": "2506_CR5", "doi-asserted-by": "crossref", "first-page": "2507", "DOI": "10.1056/NEJMoa1103782", "volume": "364", "author": "PB Chapman", "year": "2011", "unstructured": "Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O\u2019Day SJ, Sosman JA, Kirkwood JM, Eggermont AMM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364:2507\u20132516", "journal-title": "N Engl J Med"}, {"key": "2506_CR6", "doi-asserted-by": "crossref", "first-page": "444", "DOI": "10.1016/S0140-6736(15)60898-4", "volume": "386", "author": "GV Long", "year": "2015", "unstructured": "Long GV, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, Garbe C, Jouary T, Hauschild A, Grob JJ, Chiarion-Sileni V, Lebbe C, Mandal\u00e0 M, Millward M, Arance A, Bondarenko I, Haanen JBAG, Hansson J, Utikal J, Ferraresi V, Kovalenko N, Mohr P, Probachai V, Schadendorf D, Nathan P, Robert C, Ribas A, DeMarini DJ, Irani JG, Swann S, Legos JJ, Jin F, Mookerjee B, Flaherty K (2015) Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial. Lancet 386:444\u2013451", "journal-title": "Lancet"}, {"key": "2506_CR7", "doi-asserted-by": "crossref", "first-page": "1248", "DOI": "10.1016/S1470-2045(16)30122-X", "volume": "17", "author": "PA Ascierto", "year": "2016", "unstructured": "Ascierto PA, McArthur GA, Dr\u00e9no B, Atkinson V, Liszkay G, Di Giacomo AM et al (2016) Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial. Lancet Oncol. 17:1248\u20131260", "journal-title": "Lancet Oncol."}, {"key": "2506_CR8", "doi-asserted-by": "crossref", "first-page": "1767", "DOI": "10.1200/JCO.2012.44.7888", "volume": "31", "author": "K Trunzer", "year": "2013", "unstructured": "Trunzer K, Pavlick AC, Schuchter L et al (2013) Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma. J Clin Oncol 31:1767\u20131774", "journal-title": "J Clin Oncol"}, {"key": "2506_CR9", "doi-asserted-by": "crossref", "first-page": "683", "DOI": "10.1016/j.ccr.2010.11.023", "volume": "18", "author": "J Villanueva", "year": "2010", "unstructured": "Villanueva J, Vultur A, Lee JT, Somasundaram R, Fukunaga-Kalabis M, Cipolla AK, Wubbenhorst B, Xu X, Gimotty PA, Kee D, Santiago-Walker AE, Letrero R, D\u2019Andrea K, Pushparajan A, Hayden JE, Brown KD, Laquerre S, McArthur GA, Sosman JA, Nathanson KL, Herlyn M (2010) Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K. Cancer Cell 18:683\u2013695", "journal-title": "Cancer Cell"}, {"key": "2506_CR10", "doi-asserted-by": "crossref", "first-page": "1401", "DOI": "10.1038/nm.3392", "volume": "19", "author": "P Lito", "year": "2013", "unstructured": "Lito P, Rosen N, Solit DB (2013) Tumor adaptation and resistance to RAF inhibitors. Nat Med 19:1401\u20131409", "journal-title": "Nat Med"}, {"issue": "12", "key": "2506_CR11", "doi-asserted-by": "crossref", "first-page": "1743", "DOI": "10.1016/S1470-2045(16)30578-2", "volume": "17", "author": "GV Long", "year": "2016", "unstructured": "Long GV, Grob JJ, Nathan P, Ribas A, Robert C, Schadendorf D, Lane SR, Mak C, Legenne P, Flaherty KT, Davies MA (2016) Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials. Lancet Oncol 17(12):1743\u20131754", "journal-title": "Lancet Oncol"}, {"key": "2506_CR12", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1016/j.ejca.2017.05.033", "volume": "82", "author": "D Schadendorf", "year": "2017", "unstructured": "Schadendorf D, Long GV, Stroiakovski D, Karaszewska B, Hauschild A, Levchenko E, Chiarion-Sileni V, Schachter J, Garbe C, Dutriaux C, Gogas H, Mandal\u00e0 M, Haanen JBAG, Lebb\u00e9 C, Mackiewicz A, Rutkowski P, Grob JJ, Nathan P, Ribas A, Davies MA, Zhang Y, Kaper M, Mookerjee B, Legos JJ, Flaherty KT, Robert C (2017) Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials. Eur J Cancer 82:45\u201355", "journal-title": "Eur J Cancer"}, {"key": "2506_CR13", "doi-asserted-by": "crossref", "first-page": "2521", "DOI": "10.1056/NEJMoa1503093", "volume": "372", "author": "C Robert", "year": "2015", "unstructured": "Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L et al (2015) Pembrolizumab vs ipilimumab in advanced melanoma. N Engl J Med 372:2521\u20132532", "journal-title": "N Engl J Med"}, {"key": "2506_CR14", "doi-asserted-by": "crossref", "first-page": "2443", "DOI": "10.1056/NEJMoa1200690", "volume": "366", "author": "SL Topalian", "year": "2012", "unstructured": "Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF et al (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366:2443\u20132454", "journal-title": "N Engl J Med"}, {"key": "2506_CR15", "doi-asserted-by": "crossref", "first-page": "1889", "DOI": "10.1200/JCO.2014.56.2736", "volume": "17", "author": "D Schadendorf", "year": "2015", "unstructured": "Schadendorf D, Hodi FS, Robert C, Weber JS, Margolin K, Hamid O et al (2015) Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma. J Clin Oncol 17:1889\u20131894", "journal-title": "J Clin Oncol"}, {"key": "2506_CR16", "doi-asserted-by": "crossref", "first-page": "1845", "DOI": "10.1056/NEJMoa1611299", "volume": "375", "author": "AM Eggermont", "year": "2016", "unstructured": "Eggermont AM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H et al (2016) Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy. N Engl J Med 375:1845\u20131855", "journal-title": "N Engl J Med"}, {"key": "2506_CR17", "doi-asserted-by": "crossref", "first-page": "1824", "DOI": "10.1056/NEJMoa1709030", "volume": "377", "author": "J Weber", "year": "2017", "unstructured": "Weber J, Mandala M, Del Vecchio M, Gogas HJ, Arance AM, Cowey CL et al (2017) Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med 377:1824\u20131835", "journal-title": "N Engl J Med"}, {"key": "2506_CR18", "doi-asserted-by": "crossref", "first-page": "1789", "DOI": "10.1056/NEJMoa1802357", "volume": "378", "author": "AMM Eggermont", "year": "2018", "unstructured": "Eggermont AMM, Blank CU, Mandala M (2018) Adjuvant pembrolizumab versus placebo in resected stage III melanoma. N Engl J Med 378:1789\u20131801", "journal-title": "N Engl J Med"}, {"key": "2506_CR19", "unstructured": "Caroline Robert, Antoni Ribas, Omid Hamid, et al. Durable complete response after discontinuation of pembrolizumab in patients with metastatic melanoma J Clin Oncol \nhttps://doi.org/10.1200/JCO.2017.75.6270\n\n, 2018", "DOI": "10.1200/JCO.2017.75.6270", "doi-asserted-by": "publisher"}, {"key": "2506_CR20", "doi-asserted-by": "crossref", "first-page": "1345", "DOI": "10.1056/NEJMoa1709684", "volume": "377", "author": "JD Wolchok", "year": "2017", "unstructured": "Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, Grob JJ, Cowey CL, Lao CD, Wagstaff J, Schadendorf D, Ferrucci PF, Smylie M, Dummer R, Hill A, Hogg D, Haanen J, Carlino MS, Bechter O, Maio M, Marquez-Rodas I, Guidoboni M, McArthur G, Lebb\u00e9 C, Ascierto PA, Long GV, Cebon J, Sosman J, Postow MA, Callahan MK, Walker D, Rollin L, Bhore R, Hodi FS, Larkin J (2017) Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med 377:1345\u20131356", "journal-title": "N Engl J Med"}, {"key": "2506_CR21", "unstructured": "Lebb\u00e9 C, Meyer N, Mortier L, Marquez-Rodas I, Robert C, Rutkowski P (2018) Initial results from a phase IIIb/IV study evaluating two dosing regimens of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (CheckMate 511) LBA47 abstract. Ann Oncol (suppl_8)"}, {"key": "2506_CR22", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1016/j.ctrv.2016.11.007", "volume": "52", "author": "JS O\u2019Donnell", "year": "2017", "unstructured": "O\u2019Donnell JS, Long GV, Scolyer RA, Teng MW, Smyth MJ (2017) Resistance to PD1/PDL1 checkpoint inhibition. Cancer Treat Rev 52:71\u201381", "journal-title": "Cancer Treat Rev"}, {"issue": "2", "key": "2506_CR23", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.1111/joim.12708", "volume": "283", "author": "PS Chowdhury", "year": "2018", "unstructured": "Chowdhury PS, Chamoto K, Honjo T (2018) Combination therapy strategies for improving PD-1 blockade efficacy: a new era in cancer immunotherapy. J Intern Med 283(2):110\u2013120", "journal-title": "J Intern Med"}, {"key": "2506_CR24", "doi-asserted-by": "crossref", "first-page": "1344", "DOI": "10.1158/2326-6066.CIR-15-0097", "volume": "3", "author": "DS Thommen", "year": "2015", "unstructured": "Thommen DS, Schreiner J, Muller P, Herzig P, Roller A, Belousov A, Umana P, Pisa P, Klein C, Bacac M, Fischer OS, Moersig W, Savic Prince S, Levitsky V, Karanikas V, Lardinois D, Zippelius A (2015) (2015) progression of lung cancer is associated with increased dysfunction of T cells defined by coexpression of multiple inhibitory receptors. Cancer Immunol Res 3:1344\u20131355", "journal-title": "Cancer Immunol Res"}, {"key": "2506_CR25", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1016/j.ccell.2018.03.005", "volume": "33", "author": "R Zappasodi", "year": "2018", "unstructured": "Zappasodi R, Merghoub T, Wolchok JD (2018) Emerging concepts for immune checkpoint blockade-based combination therapies. Cancer Cell 33:581\u2013598", "journal-title": "Cancer Cell"}, {"issue": "3", "key": "2506_CR26", "doi-asserted-by": "crossref", "first-page": "417", "DOI": "10.1016/j.immuni.2018.03.007", "volume": "48", "author": "SA Patel", "year": "2018", "unstructured": "Patel SA, Minn AJ (2018) Combination cancer therapy with immune checkpoint blockade: mechanisms and strategies. Immunity 48(3):417\u2013433", "journal-title": "Immunity"}, {"key": "2506_CR27", "unstructured": "Sakuishi K, Apetoh L, Sullivan J.M., Sullivan JM, Blazar BR, Kuchroo VK, Anderson AC Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med 2010; 207: 2187\u20132194", "DOI": "10.1084/jem.20100643", "doi-asserted-by": "crossref"}, {"issue": "suppl", "key": "2506_CR28", "doi-asserted-by": "crossref", "first-page": "9520", "DOI": "10.1200/JCO.2017.35.15_suppl.9520", "volume": "35", "author": "P Ascierto", "year": "2017", "unstructured": "Ascierto P, Melero I, Bhatia S et al (2017) Initial efficacy of anti-lymphocyte activation gene-3 (anti\u2013LAG-3; BMS-986016) in combination with nivolumab (nivo) in pts with melanoma (MEL) previously treated with anti\u2013PD-1/PD-L1 therapy. J Clin Oncol 35(suppl):9520\u20139520", "journal-title": "J Clin Oncol"}, {"key": "2506_CR29", "doi-asserted-by": "crossref", "first-page": "10501", "DOI": "10.1038/ncomms10501", "volume": "7", "author": "S Koyama", "year": "2016", "unstructured": "Koyama S, Akbay EA, Li YY et al (2016) Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints. Nat Commun 7:10501", "journal-title": "Nat Commun"}, {"key": "2506_CR30", "doi-asserted-by": "crossref", "first-page": "6682", "DOI": "10.1073/pnas.1420370112", "volume": "112", "author": "J Liu", "year": "2015", "unstructured": "Liu J, Yuan Y, Chen W, Putra J, Suriawinata AA, Schenk AD, Miller HE, Guleria I, Barth RJ, Huang YH, Wang L (2015) Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses. Proc Natl Acad Sci U S A 112:6682\u20136687", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "2506_CR31", "doi-asserted-by": "crossref", "first-page": "577", "DOI": "10.1084/jem.20100619", "volume": "208", "author": "L Wang", "year": "2011", "unstructured": "Wang L, Rubinstein R, Lines JL, Wasiuk A, Ahonen C, Guo Y, Lu LF, Gondek D, Wang Y, Fava RA, Fiser A, Almo S, Noelle RJ (2011) VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses. J Exp Med 208:577\u2013592", "journal-title": "J Exp Med"}, {"issue": "suppl", "key": "2506_CR32", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1634/theoncologist.13-S4-2", "volume": "13", "author": "JD Wolchok", "year": "2008", "unstructured": "Wolchok JD, Saenger Y (2008) The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activation. Oncologist 13(suppl):2\u20139", "journal-title": "Oncologist"}, {"key": "2506_CR33", "doi-asserted-by": "crossref", "first-page": "9543", "DOI": "10.1128/MCB.25.21.9543-9553.2005", "volume": "25", "author": "RV Parry", "year": "2005", "unstructured": "Parry RV, Chemnitz JM, Frauwirth KA, Lanfranco AR, Braunstein I, Kobayashi SV, Linsley PS, Thompson CB, Riley JL (2005) CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol 25:9543\u20139553", "journal-title": "Mol Cell Biol"}, {"key": "2506_CR34", "doi-asserted-by": "crossref", "first-page": "917", "DOI": "10.1158/0008-5472.CAN-11-1620", "volume": "72", "author": "SR Woo", "year": "2012", "unstructured": "Woo SR, Turnis ME, Goldberg MV, Bankoti J, Selby M, Nirschl CJ, Bettini ML, Gravano DM, Vogel P, Liu CL, Tangsombatvisit S, Grosso JF, Netto G, Smeltzer MP, Chaux A, Utz PJ, Workman CJ, Pardoll DM, Korman AJ, Drake CG, Vignali DAA (2012) Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape. Cancer Res 72:917\u2013927", "journal-title": "Cancer Res"}, {"key": "2506_CR35", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1038/nri3790", "volume": "15", "author": "LT Nguyen", "year": "2015", "unstructured": "Nguyen LT, Ohashi PS (2015) Clinical blockade of PD1 and LAG3 potential mechanisms of action. Nat Rev Immunol 15:45\u201356", "journal-title": "Nat Rev Immunol"}, {"key": "2506_CR36", "doi-asserted-by": "crossref", "first-page": "640", "DOI": "10.1053/j.seminoncol.2015.05.014", "volume": "42", "author": "MF Sanmamed", "year": "2015", "unstructured": "Sanmamed MF, Pastor F, Rodriguez A, Perez-Gracia JL, Rodriguez-Ruiz ME, Jure-Kunkel M, Melero I (2015) Agonists of co-stimulation in cancer immunotherapy directed against CD137, OX40, GITR, CD27, CD28, and ICOS. Semin Oncol 42:640\u2013655", "journal-title": "Semin Oncol"}, {"key": "2506_CR37", "doi-asserted-by": "crossref", "first-page": "475", "DOI": "10.1038/icb.2014.26", "volume": "92", "author": "Y Bulliard", "year": "2014", "unstructured": "Bulliard Y, Jolicoeur R, Zhang J, Dranoff G, Wilson NS, Brogdon JL (2014) OX40 engagement depletes intratumoral Tregs via activating FcgammaRs, leading to antitumor efficacy. Immunol Cell Biol 92:475\u2013480", "journal-title": "Immunol Cell Biol"}, {"key": "2506_CR38", "doi-asserted-by": "crossref", "first-page": "e89350", "DOI": "10.1371/journal.pone.0089350", "volume": "9", "author": "Z Guo", "year": "2014", "unstructured": "Guo Z, Wang X, Cheng D, Xia Z, Luan M, Zhang S (2014) PD-1 blockade and OX40 triggering synergistically protects against tumor growth in a murine model of ovarian cancer. PLoS One 9:e89350", "journal-title": "PLoS One"}, {"key": "2506_CR39", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1200/JCO.2016.34.15_suppl.101", "volume": "34", "author": "JR Infante", "year": "2016", "unstructured": "Infante JR, Hansen AR, Pishvaian MJ et al (2016) A phase Ib dose escalation study of the OX40 agonist MOXR0916 and the PD-L1 inhibitor atezolizumab in patients with advanced solid tumors. J Clin Oncol 34:101", "journal-title": "J Clin Oncol"}, {"key": "2506_CR40", "doi-asserted-by": "crossref", "first-page": "3027", "DOI": "10.1200/JCO.2017.35.15_suppl.3027", "volume": "35", "author": "AB El-Khoueiry", "year": "2017", "unstructured": "El-Khoueiry AB, Hamid O, Thompson JA et al (2017) The relationship of pharmacodynamics (PD) and pharmacokinetics (PK) to clinical outcomes in a phase I study of OX40 agonistic monoclonal antibody (mAb) PF- 04518600 (PF 8600). J Clin Oncol 35:3027", "journal-title": "J Clin Oncol"}, {"key": "2506_CR41", "first-page": "TPS3093", "volume": "33", "author": "TM Bauer", "year": "2015", "unstructured": "Bauer TM, Chae YK, Patel S et al (2015) A phase I study of MEDI6383, an OX40 agonist, in adult patients with select advanced solid tumors. J Clin Oncol 33:TPS3093", "journal-title": "J Clin Oncol"}, {"key": "2506_CR42", "unstructured": "Siu LL, Steeghs N, Meniawy T, et al Preliminary results of a phase I/IIa study of BMS-986156 (glucocorticoid-induced tumor necrosis factor receptor\u2013related gene [GITR] agonist), alone and in combination with nivolumab in patients with advanced solid tumors. 2017 ASCO Annual Meeting. Abstract 104"}, {"key": "2506_CR43", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1158/2159-8290.CD-15-0510", "volume": "6", "author": "AR Sanchez-Paulete", "year": "2016", "unstructured": "Sanchez-Paulete AR, Cueto FJ, Martinez-Lopez M, Labiano S, Morales-Kastresana A, Rodriguez-Ruiz ME, Jure-Kunkel M, Azpilikueta A, Aznar MA, Quetglas JI, Sancho D, Melero I (2016) Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells. Cancer Discov 6:71\u201379", "journal-title": "Cancer Discov"}, {"key": "2506_CR44", "doi-asserted-by": "crossref", "first-page": "1929", "DOI": "10.1158/1078-0432.CCR-16-1272", "volume": "23", "author": "NH Segal", "year": "2017", "unstructured": "Segal NH, Logan TF, Hodi FS, McDermott D, Melero I, Hamid O, Schmidt H, Robert C, Chiarion-Sileni V, Ascierto PA, Maio M, Urba WJ, Gangadhar TC, Suryawanshi S, Neely J, Jure-Kunkel M, Krishnan S, Kohrt H, Sznol M, Levy R (2017) Results from an integrated safety analysis of urelumab, an agonist anti-CD137 monoclonal antibody. Clin Cancer Res 23:1929\u20131936", "journal-title": "Clin Cancer Res"}, {"key": "2506_CR45", "doi-asserted-by": "crossref", "first-page": "5349", "DOI": "10.1158/1078-0432.CCR-17-1243", "volume": "23", "author": "AW Tolcher", "year": "2017", "unstructured": "Tolcher AW, Sznol M, Hu-Lieskovan S, Papadopoulos KP, Patnaik A, Rasco DW, di Gravio D, Huang B, Gambhire D, Chen Y, Thall AD, Pathan N, Schmidt EV, Chow LQM (2017) Phase Ib study of utomilumab (PF-05082566), a 4-1BB/CD137 agonist, in combination with pembrolizumab (MK-3475) in patients with advanced solid tumors. Clin Cancer Res 23:5349\u20135357", "journal-title": "Clin Cancer Res"}, {"key": "2506_CR46", "doi-asserted-by": "crossref", "first-page": "6795", "DOI": "10.1158/0008-5472.CAN-17-2285", "volume": "77", "author": "GC Prendergast", "year": "2017", "unstructured": "Prendergast GC, Malachowski WP, DuHadaway JB, Muller AJ (2017) Discovery of IDO1 inhibitors: from bench to bedside. Cancer Res 77:6795\u20136811", "journal-title": "Cancer Res"}, {"key": "2506_CR47", "doi-asserted-by": "crossref", "first-page": "3269", "DOI": "10.1158/1078-0432.CCR-16-2272", "volume": "23", "author": "GL Beatty", "year": "2017", "unstructured": "Beatty GL, O\u2019Dwyer PJ, Clark J, Shi JG, Bowman KJ, Scherle PA, Newton RC, Schaub R, Maleski J, Leopold L, Gajewski TF (2017) First-in-human phase I study of the oral inhibitor of indoleamine 2,3-dioxygenase-1 epacadostat (INCB024360) in patients with advanced solid malignancies. Clin Cancer Res 23:3269\u20133276", "journal-title": "Clin Cancer Res"}, {"key": "2506_CR48", "doi-asserted-by": "crossref", "first-page": "1109", "DOI": "10.1016/j.cell.2017.08.027", "volume": "170", "author": "A Ribas", "year": "2017", "unstructured": "Ribas A, Dummer R, Puzanov I, VanderWalde A, Andtbacka RHI, Michielin O, Olszanski AJ, Malvehy J, Cebon J, Fernandez E, Kirkwood JM, Gajewski TF, Chen L, Gorski KS, Anderson AA, Diede SJ, Lassman ME, Gansert J, Hodi FS, Long GV (2017) Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy. Cell 170:1109\u20131119", "journal-title": "Cell"}, {"key": "2506_CR49", "doi-asserted-by": "crossref", "first-page": "2780", "DOI": "10.1200/JCO.2014.58.3377", "volume": "33", "author": "RH Andtbacka", "year": "2015", "unstructured": "Andtbacka RH et al (2015) Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J Clin Oncol 33:2780\u20132788", "journal-title": "J Clin Oncol"}, {"key": "2506_CR50", "doi-asserted-by": "crossref", "first-page": "1658", "DOI": "10.1200/JCO.2017.73.7379", "volume": "36", "author": "J Chesney", "year": "2018", "unstructured": "Chesney J, Puzanov I, Collichio F, Singh P, Milhem MM, John Glaspy J (2018) Randomized, open-label phase II study evaluating the efficacy and safety of talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone in patients with advanced, unresectable melanoma. J Clin Oncol 36:1658\u20131667", "journal-title": "J Clin Oncol"}, {"key": "2506_CR51", "doi-asserted-by": "crossref", "first-page": "222", "DOI": "10.1038/nature23003", "volume": "547", "author": "U Sahin", "year": "2017", "unstructured": "Sahin U, Derhovanessian E, Miller M, Kloke BP, Simon P, L\u00f6wer M, Bukur V, Tadmor AD, Luxemburger U, Schr\u00f6rs B, Omokoko T, Vormehr M, Albrecht C, Paruzynski A, Kuhn AN, Buck J, Heesch S, Schreeb KH, M\u00fcller F, Ortseifer I, Vogler I, Godehardt E, Attig S, Rae R, Breitkreuz A, Tolliver C, Suchan M, Martic G, Hohberger A, Sorn P, Diekmann J, Ciesla J, Waksmann O, Br\u00fcck AK, Witt M, Zillgen M, Rothermel A, Kasemann B, Langer D, Bolte S, Diken M, Kreiter S, Nemecek R, Gebhardt C, Grabbe S, H\u00f6ller C, Utikal J, Huber C, Loquai C, T\u00fcreci \u00d6 (2017) Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature 547:222\u2013226", "journal-title": "Nature"}, {"key": "2506_CR52", "unstructured": "M. Milhem, R. Gonzales, T. Medina, et al Intratumoral toll-like receptor 9 (TLR9) agonist, CMP-001, in combination with pembrolizumab can reverse resistance to PD-1 inhibition in a phase Ib trial in subjects with advanced melanoma. Presented at: AACR Annual Meeting 2018; April 14\u201318, 2018; Chicago, Illinois. Abstract CT0101"}, {"key": "2506_CR53", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1186/s40425-016-0191-4", "volume": "4", "author": "R Leidner", "year": "2016", "unstructured": "Leidner R, Kang H, Haddad R et al (2016) Preliminary efficacy from a phase 1/2 study of the natural killer cell\u2013targeted antibody, lirilumab in combination with nivolumab in squamous cell carcinoma of the head and neck. J Immunother Cancer 4:91", "journal-title": "J Immunother Cancer"}, {"key": "2506_CR54", "doi-asserted-by": "crossref", "first-page": "7250", "DOI": "10.1158/0008-5472.CAN-13-3583", "volume": "74", "author": "C Cekic", "year": "2014", "unstructured": "Cekic C, Day YJ, Sag D, Linden J (2014) Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment. Cancer Res 74:7250\u20137259", "journal-title": "Cancer Res"}, {"key": "2506_CR55", "doi-asserted-by": "publisher", "first-page": "91", "DOI": "10.1016/j.semcancer.2017.04.015", "volume": "48", "author": "JS O\u2019Donnell", "year": "2017", "unstructured": "O\u2019Donnell JS, Massi D, Teng MWL, Mandala M (2017) PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux. Semin Cancer Biol 48:91\u2013103. \nhttps://doi.org/10.1016/j.semcancer.2017.04.015", "journal-title": "Semin Cancer Biol"}, {"key": "2506_CR56", "doi-asserted-by": "crossref", "first-page": "680", "DOI": "10.1158/1078-0432.CCR-15-1631", "volume": "22", "author": "DH Charych", "year": "2016", "unstructured": "Charych DH, Hoch U, Langowski JL, Lee SR, Addepalli MK, Kirk PB, Sheng D, Liu X, Sims PW, VanderVeen LA, Ali CF, Chang TK, Konakova M, Pena RL, Kanhere RS, Kirksey YM, Ji C, Wang Y, Huang J, Sweeney TD, Kantak SS, Doberstein SK (2016) NKTR-214, an engineered cytokine with biased IL2 receptor binding, increased tumor exposure, and marked efficacy in mouse tumor models. Clin Cancer Res 22:680\u2013690", "journal-title": "Clin Cancer Res"}, {"key": "2506_CR57", "unstructured": "Diab A, Hurwitz ME, Cho DC, Papadimitrakopoulou V, Curti BD, Scott S et al (2016) Tykodi NKTR-214 (CD122-biased agonist) plus nivolumab in patients with advanced solid tumors: preliminary phase 1/2 results of PIVOT. ASCO meeting abstract 3006. J Clin Oncol (suppl)"}, {"key": "2506_CR58", "doi-asserted-by": "crossref", "first-page": "36", "DOI": "10.1080/15384047.2016.1264543", "volume": "18", "author": "KM Koller", "year": "2017", "unstructured": "Koller KM, Mackley HB, Liu J, Wagner H, Talamo G, Schell TD, Pameijer C, Neves RI, Anderson B, Kokolus KM, Mallon CA, Drabick JJ (2017) Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone. Cancer Biol Ther 18:36\u201342", "journal-title": "Cancer Biol Ther"}, {"key": "2506_CR59", "doi-asserted-by": "crossref", "first-page": "e1214788", "DOI": "10.1080/2162402X.2016.1214788", "volume": "5", "author": "E Liniker", "year": "2016", "unstructured": "Liniker E, Menzies AM, Kong BY, Cooper A, Ramanujam S, Lo S, Kefford RF, Fogarty GB, Guminski A, Wang TW, Carlino MS, Hong A, Long GV (2016) Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma. Oncoimmunology 5:e1214788", "journal-title": "Oncoimmunology"}, {"key": "2506_CR60", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1038/nature14292", "volume": "520", "author": "C Twyman-Saint Victor", "year": "2015", "unstructured": "Twyman-Saint Victor C, Rech AJ, Maity A, Rengan R, Pauken KE, Stelekati E, Benci JL, Xu B, Dada H, Odorizzi PM, Herati RS, Mansfield KD, Patsch D, Amaravadi RK, Schuchter LM, Ishwaran H, Mick R, Pryma DA, Xu X, Feldman MD, Gangadhar TC, Hahn SM, Wherry EJ, Vonderheide RH, Minn AJ (2015) Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature 520:373\u2013377", "journal-title": "Nature"}, {"key": "2506_CR61", "doi-asserted-by": "crossref", "first-page": "578", "DOI": "10.1016/j.ijrobp.2016.07.005", "volume": "96", "author": "SM Hiniker", "year": "2016", "unstructured": "Hiniker SM, Reddy SA, Maecker HT, Subrahmanyam PB, Rosenberg-Hasson Y, Swetter SM, Saha S, Shura L, Knox SJ (2016) A prospective clinical trial combining radiation therapy with systemic immunotherapy in metastatic melanoma. Int J Radiat Oncol Biol Phys 96:578\u2013588", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "2506_CR62", "doi-asserted-by": "crossref", "first-page": "142", "DOI": "10.1016/j.cell.2017.06.007", "volume": "170", "author": "HE Ghoneim", "year": "2017", "unstructured": "Ghoneim HE, Fan Y, Moustaki A, Abdelsamed HA, Dash P, Dogra P, Carter R, Awad W, Neale G, Thomas PG, Youngblood B et al (2017) De novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation. Cell 170:142\u2013157", "journal-title": "Cell"}, {"key": "2506_CR63", "doi-asserted-by": "crossref", "first-page": "726", "DOI": "10.1038/nrc3130", "volume": "11", "author": "SB Baylin", "year": "2011", "unstructured": "Baylin SB, Jones PA (2011) A decade of exploring the cancer epigenome biological and translational implications. Nat Rev Cancer 11:726\u2013734", "journal-title": "Nat Rev Cancer"}, {"key": "2506_CR64", "doi-asserted-by": "crossref", "first-page": "38", "DOI": "10.1016/j.cell.2013.03.008", "volume": "153", "author": "H Shen", "year": "2013", "unstructured": "Shen H, Laird PW (2013) Interplay between the cancer genome and epigenome. Cell 153:38\u201355", "journal-title": "Cell"}, {"key": "2506_CR65", "doi-asserted-by": "crossref", "first-page": "6975", "DOI": "10.1038/sj.onc.1209678", "volume": "25", "author": "SR James", "year": "2006", "unstructured": "James SR, Link PA, Karpf AR (2006) Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b. Oncogene 25:6975\u20136985", "journal-title": "Oncogene"}, {"key": "2506_CR66", "doi-asserted-by": "crossref", "first-page": "5057", "DOI": "10.1158/0008-5472.CAN-13-3723", "volume": "74", "author": "Y Zhu", "year": "2014", "unstructured": "Zhu Y, Knolhoff B, Meyer MA et al (2014) CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res 74:5057\u20135069", "journal-title": "Cancer Res"}, {"key": "2506_CR67", "doi-asserted-by": "crossref", "first-page": "1225", "DOI": "10.1158/1078-0432.CCR-12-1630", "volume": "19", "author": "DT Frederick", "year": "2013", "unstructured": "Frederick DT, Piris A, Cogdill AP, Cooper ZA, Lezcano C, Ferrone CR, Mitra D, Boni A, Newton LP, Liu C, Peng W, Sullivan RJ, Lawrence DP, Hodi FS, Overwijk WW, Lizee G, Murphy GF, Hwu P, Flaherty KT, Fisher DE, Wargo JA (2013) BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma. Clin Cancer Res 19:1225\u20131231", "journal-title": "Clin Cancer Res"}, {"issue": "6", "key": "2506_CR68", "doi-asserted-by": "crossref", "first-page": "1271e85", "DOI": "10.1016/j.cell.2015.07.061", "volume": "162", "author": "W Hugo", "year": "2015", "unstructured": "Hugo W, Shi H, Sun L, Piva M, Song C, Kong X et al (2015) Nongenomic and immune evolution of melanoma acquiring MAPKi resistance. Cell 162(6):1271e85", "journal-title": "Cell"}, {"issue": "7559", "key": "2506_CR69", "doi-asserted-by": "crossref", "first-page": "231e5", "DOI": "10.1038/nature14404", "volume": "523", "author": "S Spranger", "year": "2015", "unstructured": "Spranger S, Bao R, Gajewski TF (2015) Melanoma-intrinsic betacatenin signalling prevents anti-tumour immunity. Nature 523(7559):231e5", "journal-title": "Nature"}, {"key": "2506_CR70", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1016/j.ejca.2017.03.012", "volume": "78", "author": "D Massi", "year": "2017", "unstructured": "Massi D, Romano E, Rulli E, Merelli B, Nassini R, De Logu F, Bieche I, Baroni G, Cattaneo L, Xue G, Mandal\u00e0 M (2017) Baseline \u00df-catenin, PD-L1 expression and tumor-infiltrating lymphocytes predict response and poor prognosis in BRAFi-treated melanoma patients. Eur J Cancer 78:70\u201381", "journal-title": "Eur J Cancer"}, {"key": "2506_CR71", "doi-asserted-by": "crossref", "first-page": "1980", "DOI": "10.1093/annonc/mdv255", "volume": "26", "author": "D Massi", "year": "2015", "unstructured": "Massi D, Brusa D, Merelli B, Falcone C, Xue G, Carobbio A, Nassini R, Baroni G, Tamborini E, Cattaneo L, Audrito V, Deaglio S, Mandal\u00e0 M (2015) The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600. Ann Oncol 26:1980\u20131987", "journal-title": "Ann Oncol"}, {"key": "2506_CR72", "doi-asserted-by": "crossref", "first-page": "500", "DOI": "10.1038/nature11183", "volume": "487", "author": "R Straussman", "year": "2012", "unstructured": "Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, du J, Davis A, Mongare MM, Gould J, Frederick DT, Cooper ZA, Chapman PB, Solit DB, Ribas A, Lo RS, Flaherty KT, Ogino S, Wargo JA, Golub TR (2012) Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 487:500\u2013504", "journal-title": "Nature"}, {"key": "2506_CR73", "doi-asserted-by": "crossref", "first-page": "1214", "DOI": "10.1158/2159-8290.CD-13-1007", "volume": "4", "author": "MP Smith", "year": "2014", "unstructured": "Smith MP, Sanchez-Laorden B, O\u2019Brien K, Brunton H, Ferguson J, Young H, Dhomen N, Flaherty KT, Frederick DT, Cooper ZA, Wargo JA, Marais R, Wellbrock C (2014) The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNF\u03b1. Cancer Discov 4:1214\u20131229", "journal-title": "Cancer Discov"}, {"key": "2506_CR74", "doi-asserted-by": "crossref", "first-page": "1365", "DOI": "10.1056/NEJMc1302338", "volume": "368", "author": "A Ribas", "year": "2013", "unstructured": "Ribas A, Hodi FS, Callahan M, Konto C, Wolchok J (2013) Hepatotoxicity with combination of vemurafenib and ipilimumab. N Engl J Med 368:1365\u20131366", "journal-title": "N Engl J Med"}, {"key": "2506_CR75", "unstructured": "Ribas AF, Hodi S, Lawrence DP, et al (2016) Pembrolizumab (pembro) in combination with dabrafenib (D) and trametinib (T) for BRAF-mutant advanced melanoma: phase 1 KEYNOTE-022 study. J Clin Oncol 34, 2016 (suppl; abstr 3014) ASCO Abstract 3014", "DOI": "10.1200/JCO.2016.34.15_suppl.3014", "doi-asserted-by": "crossref"}, {"key": "2506_CR76", "unstructured": "Ascierto P, Ferrucci PF, Stephens R, Del Vecchio M, Atkinson V, Schmidt H et al (2018) KEYNOTE-022 part 3: phase 2 randomized study of 1L dabrafenib (D) and trametinib (T) plus pembrolizumab (Pembro) or placebo (PBO) for BRAF-mutant advanced melanoma. Abstract 12440 ESMO meeting 2018. Ann Oncol 29(suppl 8)"}, {"key": "2506_CR77", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1186/s12967-016-0791-2", "volume": "14", "author": "R Sullivan", "year": "2016", "unstructured": "Sullivan R, Hamid O, Patel M et al (2016) Melanoma and immunotherapy bridge 2015. Naples, Italy. 1\u20135 December 2015. J Transl Med 14:65", "journal-title": "J Transl Med"}, {"key": "2506_CR78", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1016/j.ejca.2018.02.022", "volume": "96", "author": "D Verver", "year": "2018", "unstructured": "Verver D, van Klaveren D, van Akkooi ACJ, Rutkowski P, Powell BW, Robert C et al (2018) Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations. Eur J Cancer 96:25\u201333", "journal-title": "Eur J Cancer"}, {"key": "2506_CR79", "unstructured": "Hauschild A, Dummer R, Schadendorf D, Santinami M, Atkinson V, Mandal\u00e0 M et al (2018) Sustained relapse-free survival benefit with adjuvant dabrafenib plus trametinib in patients with resected BRAF V600-mutant stage III melanoma. J Clin Oncol. \nhttps://doi.org/10.1001/jamaoncol.2018.4514", "DOI": "10.1001/jamaoncol.2018.4514", "doi-asserted-by": "publisher"}, {"key": "2506_CR80", "doi-asserted-by": "crossref", "first-page": "2211", "DOI": "10.1056/NEJMoa1613210", "volume": "376", "author": "MB Faries", "year": "2017", "unstructured": "Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters MWJM, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DSB, Wang HJ, Elashoff DA, Elashoff RM (2017) Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med 376:2211\u20132222", "journal-title": "N Engl J Med"}, {"key": "2506_CR81", "doi-asserted-by": "crossref", "first-page": "757", "DOI": "10.1016/S1470-2045(16)00141-8", "volume": "17", "author": "U Leiter", "year": "2016", "unstructured": "Leiter U, Stadler R, Mauch C, Hohenberger W, Brockmeyer N, Berking C, Sunderk\u00f6tter C, Kaatz M, Schulte KW, Lehmann P, Vogt T, Ulrich J, Herbst R, Gehring W, Simon JC, Keim U, Martus P, Garbe C (2016) Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol 17:757\u2013767", "journal-title": "Lancet Oncol"}, {"issue": "6286", "key": "2506_CR82", "doi-asserted-by": "crossref", "first-page": "658", "DOI": "10.1126/science.aaf2834", "volume": "352", "author": "CU Blank", "year": "2016", "unstructured": "Blank CU, Haanen JB, Ribas A, Schumacher TN (2016) CANCER IMMUNOLOGY. The \u201ccancer immunogram\u201d. Science 352(6286):658\u2013660", "journal-title": "Science"}, {"key": "2506_CR83", "doi-asserted-by": "crossref", "first-page": "1366", "DOI": "10.1126/science.aar6918", "volume": "359", "author": "L Zitvogel", "year": "2018", "unstructured": "Zitvogel L, Ma Y, Raoult D, Kroemer G, Gajewski TF (2018) The microbiome in cancer immunotherapy: diagnostic tools and therapeutic strategies. Science 359:1366\u20131370", "journal-title": "Science"}], "container-title": ["Virchows Archiv"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00428-018-2506-y.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00428-018-2506-y/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00428-018-2506-y.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 12, 14]], "date-time": "2018-12-14T07:40:44Z", "timestamp": 1544773244000}, "score": 21.802963, "issued": {"date-parts": [[2018, 12, 14]]}, "references-count": 83, "alternative-id": ["2506"], "URL": "http://dx.doi.org/10.1007/s00428-018-2506-y", "relation": {"cites": []}, "ISSN": ["0945-6317", "1432-2307"], "issn-type": [{"value": "0945-6317", "type": "print"}, {"value": "1432-2307", "type": "electronic"}], "subject": ["Pathology and Forensic Medicine", "Cell Biology", "Molecular Biology", "General Medicine"]}, {"indexed": {"date-parts": [[2018, 11, 9]], "date-time": "2018-11-09T23:41:14Z", "timestamp": 1541806874073}, "reference-count": 44, "publisher": "S. Karger AG", "issue": "5", "license": [{"URL": "https://www.karger.com/Services/SiteLicenses", "start": {"date-parts": [[2018, 1, 1]], "date-time": "2018-01-01T00:00:00Z", "timestamp": 1514764800000}, "delay-in-days": 0, "content-version": "vor"}, {"URL": "https://www.karger.com/Services/SiteLicenses", "start": {"date-parts": [[2018, 1, 1]], "date-time": "2018-01-01T00:00:00Z", "timestamp": 1514764800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Visc Med"], "published-print": {"date-parts": [[2018]]}, "DOI": "10.1159/000491649", "type": "journal-article", "created": {"date-parts": [[2018, 8, 23]], "date-time": "2018-08-23T21:01:36Z", "timestamp": 1535058096000}, "page": "347-352", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Is the Surgical Margin in Gastrointestinal Stromal Tumors Different?"], "prefix": "10.1159", "volume": "34", "author": [{"given": "Piotr", "family": "Rutkowski", "sequence": "first", "affiliation": []}, {"given": "Jacek", "family": "Skoczylas", "sequence": "additional", "affiliation": []}, {"given": "Piotr", "family": "Wisniewski", "sequence": "additional", "affiliation": []}], "member": "127", "published-online": {"date-parts": [[2018, 8, 24]]}, "reference": [{"key": "ref1", "unstructured": "Miettinen M, Furlong M, Sarlomo-Rikala M, Burke A, Sobin LH, Lasota J: Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol 2001;25:1121-1133.", "DOI": "10.1097/00000478-200109000-00002", "doi-asserted-by": "publisher"}, {"key": "ref2", "unstructured": "Rutkowski P, Nowecki ZI, Michej W, et al: Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor. Ann Surg Oncol 2007;14:2018-2027.", "DOI": "10.1245/s10434-007-9377-9", "doi-asserted-by": "publisher"}, {"key": "ref3", "unstructured": "Rutkowski P, Hompes D: Combined therapy of gastrointestinal stromal tumors. Surg Oncol Clin N Am 2016;25:735-759.", "DOI": "10.1016/j.soc.2016.05.006", "doi-asserted-by": "publisher"}, {"key": "ref4", "unstructured": "Miettinen M, Kopczynski J, Makhlouf HR, Sarlomo-Rikala M, Gyorffy H, Burke A, Sobin LH, Lasota J: Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 2003;27:625-641.", "DOI": "10.1097/00000478-200305000-00006", "doi-asserted-by": "publisher"}, {"key": "ref5", "unstructured": "Miettinen M, Lasota J, Sobin LH: Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature. Am J Surg Pathol 2005;29:1373-1381.", "DOI": "10.1097/01.pas.0000172190.79552.8b", "doi-asserted-by": "publisher"}, {"key": "ref6", "unstructured": "Miettinen M, Makhlouf H, Sobin LH, Lasota J: Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol 2006;30:477-489.", "DOI": "10.1097/00000478-200604000-00008", "doi-asserted-by": "publisher"}, {"key": "ref7", "unstructured": "Miettinen M, Lasota J: Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006;23:70-83.", "DOI": "10.1053/j.semdp.2006.09.001", "doi-asserted-by": "publisher"}, {"key": "ref8", "unstructured": "Edge SB, Compton CC: The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471-1474.", "DOI": "10.1245/s10434-010-0985-4", "doi-asserted-by": "publisher"}, {"key": "ref9", "unstructured": "Rutkowski P, Bylina E, Wozniak A, et al: Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour - the impact of tumour rupture on patient outcomes. Eur J Surg Oncol 2011;37:890-896.", "DOI": "10.1016/j.ejso.2011.06.005", "doi-asserted-by": "publisher"}, {"key": "ref10", "unstructured": "Joensuu H: Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 2008;39:1411-1419.", "DOI": "10.1016/j.humpath.2008.06.025", "doi-asserted-by": "publisher"}, {"key": "ref11", "unstructured": "Joensuu H, Vehtari A, Riihim\u00e4ki J, et al: Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol 2012;13:265-274.", "DOI": "10.1016/S1470-2045(11)70299-6", "doi-asserted-by": "publisher"}, {"key": "ref12", "unstructured": "Pierie JP, Choudry U, Muzikansky A, Yeap BY, Souba WW, Ott MJ: The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 2001;136:383-389.", "DOI": "10.1001/archsurg.136.4.383", "doi-asserted-by": "publisher"}, {"key": "ref13", "unstructured": "Kim SG: Interpretation of pathologic margin after endoscopic resection of gastrointestinal stromal tumor. Clin Endosc 2016;49:229-231.", "DOI": "10.5946/ce.2016.035", "doi-asserted-by": "publisher"}, {"key": "ref14", "unstructured": "The ESMO/European Sarcoma Network Working Group: Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014;25:iii21-26.", "DOI": "10.1093/annonc/mdu255", "doi-asserted-by": "publisher"}, {"key": "ref15", "unstructured": "Everett M, Gutman H: Surgical management of gastrointestinal stromal tumors: analysis of outcome with respect to surgical margins and technique. J Surg Oncol 2008;98:588-593.", "DOI": "10.1002/jso.21030", "doi-asserted-by": "publisher"}, {"key": "ref16", "unstructured": "Nishimura J, Nakajima K, Omori T, Takahashi T, Nishitani A, Ito T, Nishida T: Surgical strategy for gastric gastrointestinal stromal tumors: laparoscopic vs. open resection. Surg Endosc 2007;21:875-878.", "DOI": "10.1007/s00464-006-9065-z", "doi-asserted-by": "publisher"}, {"key": "ref17", "unstructured": "Perez EA, Gutierrez JC, Jin X, Lee DJ, Rocha-Lima C, Livingstone AS, Franceschi D, Koniaris LG: Surgical outcomes of gastrointestinal sarcoma including gastrointestinal stromal tumors: a population-based examination. J Gastrointest Surg 2007;11:114-125.", "DOI": "10.1007/s11605-006-0072-0", "doi-asserted-by": "publisher"}, {"key": "ref18", "unstructured": "Iwahashi M, Takifuji K, Ojima T, et al: Surgical management of small gastrointestinal stromal tumors of the stomach. World J Surg 2006;30:28-35.", "DOI": "10.1007/s00268-005-7944-4", "doi-asserted-by": "publisher"}, {"key": "ref19", "unstructured": "Koh YX, Chok AY, Zheng HL, Tan CS, Chow PK, Wong WK, Goh BK: A systematic review and meta-analysis comparing laparoscopic versus open gastric resections for gastrointestinal stromal tumors of the stomach. Ann Surg Oncol 2013;20:3549-3560.", "DOI": "10.1245/s10434-013-3051-1", "doi-asserted-by": "publisher"}, {"key": "ref20", "unstructured": "Xiong H, Wang J, Jia Y, Ye C, Lu Y, Chen C, Shen J, Chen Y, Zhao W, Wang L, Zhou J: Laparoscopic surgery versus open resection in patients with gastrointestinal stromal tumors: an updated systematic review and meta-analysis. Am J Surg 2017;214:538-546.", "DOI": "10.1016/j.amjsurg.2017.03.042", "doi-asserted-by": "publisher"}, {"key": "ref21", "unstructured": "Chi JL, Xu M, Zhang MR, Li Y, Zhou ZG: Laparoscopic versus open resection for gastric gastrointestinal stromal tumors (GISTs): a size-location-matched case-control study. World J Surg 2017;41:2345-2352.", "DOI": "10.1007/s00268-017-4005-8", "doi-asserted-by": "publisher"}, {"key": "ref22", "unstructured": "Hu J, Or BHN, Hu K, Wang ML: Comparison of the post-operative outcomes and survival of laparoscopic versus open resections for gastric gastrointestinal stromal tumors: a multi-center prospective cohort study. Int J Surg 2016;33:65-71.", "DOI": "10.1016/j.ijsu.2016.07.064", "doi-asserted-by": "publisher"}, {"key": "ref23", "unstructured": "Joo MK, Park JJ, Kim H, Koh JS, Lee BJ, Chun HJ, Lee SW, Jang YJ, Mok YJ, Bak YT: Endoscopic versus surgical resection of GI stromal tumors in the upper GI tract. Gastrointest Endosc 2016;83:318-326.", "DOI": "10.1016/j.gie.2015.07.034", "doi-asserted-by": "publisher"}, {"key": "ref24", "unstructured": "McCarter MD, Antonescu CR, Ballman KV, et al: Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence. J Am Coll Surg 2012;215:53-59.", "DOI": "10.1016/j.jamcollsurg.2012.05.008", "doi-asserted-by": "publisher"}, {"key": "ref25", "unstructured": "Gouveia AM, Pimenta AP, Capelinha AF, de la Cruz D, Silva P, Lopes JM: Surgical margin status and prognosis of gastrointestinal stromal tumor. World J Surg 2008;32:2375-2382.", "DOI": "10.1007/s00268-008-9704-8", "doi-asserted-by": "publisher"}, {"key": "ref26", "unstructured": "Singer S, Rubin BP, Lux ML, Chen CJ, Demetri GD, Fletcher CD, Fletcher JA: Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol 2002;20:3898-3905.", "DOI": "10.1200/JCO.2002.03.095", "doi-asserted-by": "publisher"}, {"key": "ref27", "unstructured": "DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF: Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51-58.", "DOI": "10.1097/00000658-200001000-00008", "doi-asserted-by": "publisher"}, {"key": "ref28", "unstructured": "Kim MY, Park YS, Choi KD, et al: Predictors of recurrence after resection of small gastric gastrointestinal stromal tumors of 5 cm or less. J Clin Gastroenterol 2012;46:130-137.", "DOI": "10.1097/MCG.0b013e31821f8bf6", "doi-asserted-by": "publisher"}, {"key": "ref29", "unstructured": "Wu TJ, Lee LY, Yeh CN, Wu PY, Chao TC, Hwang TL, Jan YY, Chen MF: Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate. BMC Gastroenterol 2006;6:29.", "DOI": "10.1186/1471-230X-6-29", "doi-asserted-by": "publisher"}, {"key": "ref30", "unstructured": "Bucher P, Egger JF, Gervaz P, Ris F, Weintraub D, Villiger P, Buhler LH, Morel P: An audit of surgical management of gastrointestinal stromal tumours (GIST). Eur J Surg Oncol 2006;32:310-314.", "DOI": "10.1016/j.ejso.2005.11.021", "doi-asserted-by": "publisher"}, {"key": "ref31", "unstructured": "Langer C, Gunawan B, Sch\u00fcler P, Huber W, F\u00fczesi L, Becker H: Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours. Br J Surg 2003;90:332-339.", "DOI": "10.1002/bjs.4046", "doi-asserted-by": "publisher"}, {"key": "ref32", "unstructured": "Aparicio T, Boige V, Sabourin JC, Crenn P, Ducreux M, Le Cesne A, Bonvalot S: Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours. Eur J Surg Oncol 2004;30:1098-1103.", "DOI": "10.1016/j.ejso.2004.06.016", "doi-asserted-by": "publisher"}, {"key": "ref33", "unstructured": "\u00c5hl\u00e9n J, Karlsson F, Wejde J, Nilsson IL, Larsson C, Br\u00e4nstr\u00f6m R: Wide surgical margin improves the outcome for patients with gastrointestinal stromal tumors (GISTs). World J Surg 2018;42:2512-2521.", "DOI": "10.1007/s00268-018-4498-9", "doi-asserted-by": "publisher"}, {"key": "ref34", "unstructured": "Lin SC, Huang MJ, Zeng CY, Wang TI, Liu ZL, Shiay RK: Clinical manifestations and prognostic factors in patients with gastrointestinal stromal tumors. World J Gastroenterol 2003;9:2809-2812.", "DOI": "10.3748/wjg.v9.i12.2809", "doi-asserted-by": "publisher"}, {"key": "ref35", "unstructured": "Crosby JA, Catton CN, Davis A, Couture J, O'Sullivan B, Kandel R, Swallow CJ: Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. Ann Surg Oncol 2001;8:50-59.", "DOI": "10.1007/s10434-001-0050-4", "doi-asserted-by": "publisher"}, {"key": "ref36", "unstructured": "Zhi X, Jiang B, Yu J, R\u00f8e OD, Qin J, Ni Q, Sun L, Xu M, Zhu J, Ma L: Prognostic role of microscopically positive margins for primary gastrointestinal stromal tumors: a systematic review and meta-analysis. Sci Rep 2016;6:21541.", "DOI": "10.1038/srep21541", "doi-asserted-by": "publisher"}, {"key": "ref37", "unstructured": "Hohenberger P, Ronellenfitsch U, Oladeji O, Pink D, Str\u00f6bel P, Wardelmann E, Reichardt P: Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour. Br J Surg 2010;97:1854-1859.", "DOI": "10.1002/bjs.7222", "doi-asserted-by": "publisher"}, {"key": "ref38", "unstructured": "Peparini N, Chirletti P: Tumor rupture during surgery for gastrointestinal stromal tumors: pay attention! World J Gastroenterol 2013;19:2009-2010.", "DOI": "10.3748/wjg.v19.i12.2009", "doi-asserted-by": "publisher"}, {"key": "ref39", "unstructured": "H\u00f8lmebakk T, Bjerkehagen B, Boye K, Bruland \u00d8, Stoldt S, Hall KS: Definition and clinical significance of tumour rupture in gastrointestinal stromal tumours of the small intestine. Br J Surg 2016;103:684-691.", "DOI": "10.1002/bjs.10104", "doi-asserted-by": "publisher"}, {"key": "ref40", "unstructured": "Rutkowski P, Gronchi A, Hohenberger P, et al: Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience. Ann Surg Oncol 2013;20:2937-2943.", "DOI": "10.1245/s10434-013-3013-7", "doi-asserted-by": "publisher"}, {"key": "ref41", "unstructured": "Tielen R, Verhoef C, van Coevorden F, Gelderblom H, Sleijfer S, Hartgrink HH, Bonenkamp JJ, van der Graaf WT, de Wilt JH: Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib. Eur J Surg Oncol 2013;39:150-155.", "DOI": "10.1016/j.ejso.2012.09.004", "doi-asserted-by": "publisher"}, {"key": "ref42", "unstructured": "Ford SJ, Gronchi A: Indications for surgery in advanced/metastatic GIST. Eur J Cancer 2016;63:154-167.", "DOI": "10.1016/j.ejca.2016.05.019", "doi-asserted-by": "publisher"}, {"key": "ref43", "unstructured": "Tang S, Yin Y, Shen C, Chen J, Yin X, Zhang B, Yao Y, Yang J, Chen Z: Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST). World J Surg Oncol 2017;15:79.", "DOI": "10.1186/s12957-017-1143-2", "doi-asserted-by": "publisher"}, {"key": "ref44", "unstructured": "Joensuu H, Eriksson M, Hall KS, et al: Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib. Cancer 2014;120:2325-2333.", "DOI": "10.1002/cncr.28669", "doi-asserted-by": "publisher"}], "container-title": ["Visceral Medicine"], "language": "en", "link": [{"URL": "https://www.karger.com/Article/Pdf/491649", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://www.karger.com/Article/Pdf/491649", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 9]], "date-time": "2018-11-09T23:00:43Z", "timestamp": 1541804443000}, "score": 21.005066, "issued": {"date-parts": [[2018]]}, "references-count": 44, "journal-issue": {"published-online": {"date-parts": [[2018, 10, 30]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1159/000491649", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["2297-4725", "2297-475X"], "issn-type": [{"value": "2297-4725", "type": "print"}, {"value": "2297-475X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T00:49:15Z", "timestamp": 1525740555529}, "reference-count": 0, "publisher": "Schweizerbart", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["nova hedw."], "published-print": {"date-parts": [[2018, 5, 1]]}, "DOI": "10.1127/nova_hedwigia/2017/0443", "type": "journal-article", "created": {"date-parts": [[2017, 9, 26]], "date-time": "2017-09-26T01:05:12Z", "timestamp": 1506387912000}, "page": "427-440", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Presence and distribution of the rare ascomycete Stromatinia rapulum (Bull.: Fr.) Boud. (Sclerotiniaceae, Helotiales) in Central Europe with new localities from Poland"], "prefix": "10.1127", "volume": "106", "author": [{"given": "Piotr", "family": "Chachu\u0142a", "sequence": "first", "affiliation": []}, {"given": "Ryszard", "family": "Rutkowski", "sequence": "additional", "affiliation": []}, {"given": "Piotr", "family": "Mleczko", "sequence": "additional", "affiliation": []}], "member": "181", "container-title": ["Nova Hedwigia"], "language": "en", "link": [{"URL": "http://www.ingentaconnect.com/content/schweiz/novh/2018/00000106/f0020003/art00009", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T04:53:21Z", "timestamp": 1525323201000}, "score": 21.005066, "issued": {"date-parts": [[2018, 5, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2018, 5, 1]]}, "issue": "3"}, "alternative-id": ["0029-5035(20180501)106:3L.427;1-"], "URL": "http://dx.doi.org/10.1127/nova_hedwigia/2017/0443", "ISSN": ["0029-5035"], "issn-type": [{"value": "0029-5035", "type": "print"}]}], "items-per-page": 25, "query": {"start-index": 0, "search-terms": null}}, "custom_name_alias": "RUTKOWSKI PIOTR"}